\r\n\tThe objective of the proposed book is to give a multi-perspective view on role of autophagy in injury, infection and cancer diseases. The book chapters aim to elucidate autophagy pathways in sustaining the host defense mechanisms, adaptive homeostasis as well as in remodeling and regeneration events that are essential for recuperation of the affected tissues. A specific subject for discussion will be up-regulation and/or impairment of autophagy and crinophagy in phagocytes/granulocytes and adult stem cells.
\r\n
\r\n\tRationale: \r\n\tThe cell/tissue responses to acute stress, trauma/injury or pathogens are mediated by expression and release of plethora of paracrine and endocrine effectors including DAMPs, PAMPs and inflammatory cytokines, chemokines, defensins, and reactive intermediate species. These effectors drive the integrative interactome constituted by hubs of the acute phase response modules, the inflammatory response modules, the module of the adaptive homeostatic response in the damaged parenchymal cells, vascular cells, immunocompetent cells and emerging stem cells. Among these defense mechanisms is autophagy – the lysosomal pathway for processing of compromised cell constituents and/or bacterial and viral pathogens. In this light, explication of the role of autophagy in cellular pathology may arouse R&D of new modalities for management of devastating diseases such as injury, acute infections or cancer.
",isbn:null,printIsbn:"979-953-307-X-X",pdfIsbn:null,doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,hash:"3daed6048bc8ff8368c4279558f109d7",bookSignature:"Dr. Nikolai Gorbunov",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/7997.jpg",keywords:"Autophagy-related Genes, Autophagy-related Proteins, Organelle Network, Signaling Mechanisms and Modulators, Cell Damage, Tissue Damage, PAMP and DAMP, Inflammasome, Autophagy Evasion, Cancer Stem Cells, Cancer Target Therapy, Disease",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfDimensionsCitations:0,numberOfTotalCitations:0,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"September 23rd 2019",dateEndSecondStepPublish:"October 14th 2019",dateEndThirdStepPublish:"December 13th 2019",dateEndFourthStepPublish:"March 2nd 2020",dateEndFifthStepPublish:"May 1st 2020",remainingDaysToSecondStep:"a year",secondStepPassed:!0,currentStepOfPublishingProcess:5,editedByType:null,kuFlag:!1,biosketch:null,coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"180960",title:"Dr.",name:"Nikolai",middleName:null,surname:"Gorbunov",slug:"nikolai-gorbunov",fullName:"Nikolai Gorbunov",profilePictureURL:"https://mts.intechopen.com/storage/users/180960/images/system/180960.jpg",biography:"Dr. Gorbunov obtained his Ph.D. degree in Biology from the Russian Academy Sciences. Then, he was a recipient of the NRC NAS (http://sites.nationalacademies.org/pga/rap/) and the Department of Energy fellowship awards to pursue postdoctoral training in translational science at the University of Pittsburgh and the Pacific Northwest National Laboratory (https://www.emsl.pnl.gov/emslweb Washington, USA). His translational research area has encompassed molecular pathology of trauma and countermeasures against acute radiation injury that was explored at the Walter Reed Army Institute of Research (http://wrair-www.army.mil) and the Uniformed Services University of the Health Sciences. His research interests are the disease-specific mechanisms driving alterations and defense responses in organelles, cells and tissues constituting biological barriers. With this perspective, the main objectives of his research are : i) to define the key components and pathways which regulate adaptive homeostasis and sustain intrinsic resistance to the harmful exposures and mediate recovery from the produced stress, cytotoxicity and damage; and (ii) to employ the acquired knowledge for advancement of injury-specific therapeutic modalities.",institutionString:"Henry M. Jackson Foundation for the Advancement of Military Medicine",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"Uniformed Services University of the Health Sciences",institutionURL:null,country:{name:"United States of America"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"6",title:"Biochemistry, Genetics and Molecular Biology",slug:"biochemistry-genetics-and-molecular-biology"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"270941",firstName:"Sandra",lastName:"Maljavac",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/270941/images/7824_n.jpg",email:"sandra.m@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"5295",title:"Autophagy in Current Trends in Cellular Physiology and Pathology",subtitle:null,isOpenForSubmission:!1,hash:"e16382542f283b73017bdb366aff66ad",slug:"autophagy-in-current-trends-in-cellular-physiology-and-pathology",bookSignature:"Nikolai V. Gorbunov and Marion Schneider",coverURL:"https://cdn.intechopen.com/books/images_new/5295.jpg",editedByType:"Edited by",editors:[{id:"180960",title:"Dr.",name:"Nikolai",surname:"Gorbunov",slug:"nikolai-gorbunov",fullName:"Nikolai Gorbunov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6207",title:"Traumatic Brain Injury",subtitle:"Pathobiology, Advanced Diagnostics and Acute Management",isOpenForSubmission:!1,hash:"b39555959a8969f3d06634703afd3231",slug:"traumatic-brain-injury-pathobiology-advanced-diagnostics-and-acute-management",bookSignature:"Nikolai V. Gorbunov and Joseph B. Long",coverURL:"https://cdn.intechopen.com/books/images_new/6207.jpg",editedByType:"Edited by",editors:[{id:"180960",title:"Dr.",name:"Nikolai",surname:"Gorbunov",slug:"nikolai-gorbunov",fullName:"Nikolai Gorbunov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6694",title:"New Trends in Ion Exchange Studies",subtitle:null,isOpenForSubmission:!1,hash:"3de8c8b090fd8faa7c11ec5b387c486a",slug:"new-trends-in-ion-exchange-studies",bookSignature:"Selcan Karakuş",coverURL:"https://cdn.intechopen.com/books/images_new/6694.jpg",editedByType:"Edited by",editors:[{id:"206110",title:"Dr.",name:"Selcan",surname:"Karakuş",slug:"selcan-karakus",fullName:"Selcan Karakuş"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"43380",title:"Heart Diseases in Down Syndrome",doi:"10.5772/52285",slug:"heart-diseases-in-down-syndrome",body:'
1. Introduction
Down syndrome (trisomy 21) is the common disorder among chromosomal anomalies. Trisomy 21 remains the commonest with its incidence 1:650 – 1: 1000 live births (Hassold TA and Sherman S 2000). The clinical manifestations of Down syndrome (DS) are numerous and can present in any body system. The most significant include intellectual impairment, short stature, heart disease, digestive disorders and orthopedic abnormalities (Ramakrishnan V, 2011).
Cardiac malformations present at birth are an important component of pediatric cardiovascular disease and contribute a major percentage of clinically significant birth defects with an estimated prevalence of 4 to 5 per 1000 live births. It is estimated that 4 to 10 live born infants per 1000 have cardiac malformation, 40% of which are diagnosed in the first year of life.(Hoffman J I, 1990 ; Moller J H et al, 1993). Congenital heart defect are the most common of all birth defects, which is found to affect nearly 1% of newborns, and their frequency in spontaneously aborted pregnancies is estimated to be tenfold higher (Behrman RE et al.,2000). In the year 2000, prevalence of CHD in the pediatric population was estimated at approximately 623000 (320000 with single lesion, 165000 with moderately complex disease, and 138000 with highly complex CHD). (Hoffman J I et al, 2004) Among the CHD the incidence of ventricular septal defect (VSD) has been demonstrated to be high as 5% in 2 independent cohorts of 5000 serial newborns, 5000 serial premature infants. (Roguin N et al., 1995; Du Z D et al., 1996)
The causes for CHD can be categorized in to three major groups such as chromosomal, single gene disorder (10-15%) and multiple factors (85-90%). (Payne M et al., 1995)
Its association of congenital heart disease is well known. Among all cases of congenital heart diseases, 4%-10% are associated with Down syndrome, and 40%-60% of Down syndrome patients present congenital heart disease. Cardiac malformation in DS is the principal cause of mortality in the first two years of life. (Rodriguez LH, 1984; Stoll C, et al., 1998) This congenital heart disease contributes significantly to the morbidity and mortality of children with Down syndrome, who may develop congestive heart failure, pulmonary vascular disease, pneumonia, or failure to thrive. In the first few days life symptoms or signs may be absent or minimal despite the presence of significant congenital heart disease. The characteristic heart defects seen in Down syndrome derives from the abnormal development of endocardial cushions and results in a spectrum of defects involving the atrioventricular septum and valves. Accounting for approximately 63% of all DS-CHD, their lesion varies in severity from persistent of the common atrioventricular canal and membranous ventricular septal defects to ostiumprimum patency with valvular anomalies. (Cooney T P et al., 1982; Anderson R H, 1991) The specificity of atriventricularseptal defects for trisomy 21 is emphasized by the observation that individuals with Down syndrome account for 70% of all atriventricularseptal defects. (Ferencz C et al.,1997) This is followed by patent ductus arteriosus and atrial septal defects. Other forms of complex heart disease can occur including overriding aorta and Tetralogy of fallot. (Berr C and Borghi E, 1990) The hypothesis suggests the existence of a gene or gene clusters on chromosome 21 which is involved in cell adhesion and likely plays an important role in valvuloseptal morphogenesis, but when over expressed, result in the defects of Down syndrome – congenital heart disease. (Barlow G M et al., 2001)
2. Etiology and genetics
Down syndrome which is normally caused by trisomy 21 is a major cause of congenital heart disease and provides an important model with which to link individual to the pathways controlling heart development. The characteristic heart defect seen in Down syndrome derives from the abnormal development of the endocardial cushions and results in a spectrum of defects involving atrioventricular septum and valves. Accounting for approximately 63% of all DS-CHD,( Van PR et al., 1996) these lesions vary in severity from persistence of the common atrioventricular canal and membranous ventricular septal defects to Ostium primum patency with valvular anomalies. (Cooney TP et al., 1982; Anderson RH, 1991) Independent and intersecting approaches to identifying the gene(s) for DS-CHD have included mapping genes known to be involved in cardiac development (none of which localized to chromosome 21) and studying rare individuals with CHD and partial duplications of chromosome 21. There are number of genetic tests that can assist the clinician in diagnosing genetic alterations in the child with CHD. These include cytogenetic technique, fluorescence in situ hybridization (FISH), and DNA mutation analysis.(Pierpont ME et al., 2007) The studies initially suggested that subsets of the DS phenotype were associated with three copies of chromosome band 21q22.2-22.3(Rahmani Z et al., 1989; McCormick MK et al., 1989; Korenberg JR et al., 1990) and later, that DS-CHD was caused by the over expression of genes in the region including D21S55 through the telomere.(Korenberg JR etal., 1992; Delabar JM et al.,1993; Korenberg JR et al., 1994) Another work focused on the identification of a transcriptional map of DS-CHD region using a 3.5 Mb contiguous clone array covering the interval from D21S55 through MX1/2.(Hubert RS et al., 1997) Recent study speculate that the over expression of Down syndrome cell adhesion molecule may have the potential to perturb epithelial-mesenchymal transformation and/or the migration and proliferation of mesenchymal cells, and possibly thus contribute to the increased intercellular adhesion seen in DS cushion fibroblasts and abnormal cushion development seen in DS-CHD. The DSCAM gene constitutes a large part of the DS-CHD region, spanning more than 840Kb of the region between D21S3 and (PFKL) as determined from BAC contigs (Yamakawa K et al., 1998) and genomic sequence analysis.( Hattori M et al., 2000) The study for DS-CHD suggests that the candidate region for DS-CHD may be narrowed to D21S3 (Defined by VSD), through PFKL (defined by TOF), comprising 5.5 Mb. This represents significant reduction of the previously described candidate region, which spanned 10.5 Mb from D21S55 to the telomere. (Korenberg JR et al., 1992; Korenberg JR et al., 1994) This study supports the hypothesis that trisomy for a gene in the DS-CHD candidate region is essential for the production of DS-CHD including TOF and VSD, trisomy for additional genes located in the telomere and other regions likely contributes the phenotypic variability of DS-CHD.(Barlow GM et al., 2001)
3. Type of heart defects in children with Down syndrome
Atrioventricular septal defects (AVSDs)- These are the most common in children with Down syndrome.
Atrial Septal Defects (ASDs)
Patent Ductus arteriosus (PDA)
Tetralogy of Fallot (TOF)
In a study by TRJ Tubman & et al. among 34 babies of Down syndrome had congenital heart disease detected by echocardiography (13 had atrioventricularseptal defects, seven secendum atrial septal defects, six solitary patent ductusarteriosus, five isolated ventricular septal defects, and three combinations of heart defects.)(Tubman TRJ et al., 1991)
Another study showed the association between CHD and DS in atrioventricularseptal defect 56 (35%), ventricular septal defect 48 (30%),ASD 14 (8.7%), TOF 8(5%), PDA 18 (11.2%) and other heart defects 20(12.5%). (Ramakrishnan, V. 2011)
4. Presentations
4.1. Atroventricular Septal Defects (AVSDs)
These heart defects are marked by a hole in the wall between the top chambers (atria) and bottom chambers (ventricles) and one common valve between the two atria. In some cases, there might not be a hole between the bottom chambers. Or the valves may be joined together, but either or both might leak.
Because of the high pressure in the left ventricle which is needed to pump the blood around the body, blood is forced through the holes in the central heart wall (septum) when the ventricles contracts. This increases the pressure in the right ventricles. This increased pressure (pulmonary hypertension) results in excess blood flow to the lung.
Some of the early symptoms seen are difficulty in eating, weight gain, fast irregular breathing and a degree of cyanosis (blueness) particularly noticeable around the mouth, fingers and toes. Clinical examination may show an enlarged heart and liver, and a diagnosis of heart failure may be given. This term, not all children will exhibit symptoms early in life, and those that do will not always show all of these features.
4.2. Ventricular Septal Defects (VSDs)
In this defect there is a hole between the bottom clambers (pumping chambers or ventricles). Because of the higher pressure in the left side of the heart this allows oxygenated blood to flow through the hole from the left to the right side of the heart and back to the lungs in addition to the normal flow. The amount of blood flow from the left to right ventricle depends on the size of the hole and on the pressure between the ventricles. In other words, the higher the rate of flow means more strain on the heart. The abnormal blood flow is responsible for the murmur that may be heard.
Generally patients with a small VSD will not exhibit symptoms (they are asymptomatic) and the problem may only be found when a murmur is detected upon routine examination. Patients with a moderate VSD may breathe quickly, exhibit poor weight gain and be slower at eating. These children are also much more prone to chest infection. This tends to be more pronounced when the hole is large.
4.3. Atrial Septal Defects (ASDs)
In this defect there is a hole between the top chambers (receiving chambers or atria). Because of the higher pressure in the left side of the heart, oxygenated blood flows through the hole from the left to the right side, and back to the lungs, in addition to the normal flow.
There are three types of atrial septal defects; the most common is when there is a hole in the middle of the central heart wall. Holes in the lower part of the septum, called primum defect (partial atrioventricularseptal defect), are often associated with a problem of the mitral valve that often results in a leak. Less common are sinus venosus defects or holes in the top of the septum. These are associated with an abnormality of the right upper lung vein.
Generally patients with an ASD defect will exhibit no symptoms and the problem is only found when a routine clinical examination detects a heart murmur. Occasionally children with this problem will exhibit poor weight gain and a failure to thrive, and if there is mitral valve leakage there may be early symptoms of breathlessness.
4.4. Patent Ductus Anteriosus (PDA)
This defect is the continuance of a direct connection between the aorta and the lung (pulmonary) artery, which normally closes shortly after birth. A baby in the womb is supplied oxygen by the placenta via the umbilical cord. The baby’s lungs are not expanded and require only a small amount blood for them to grow. The ductus is a blood vessel that allows blood to bypass the baby’s lungs.
If the ductus has partially closed and only a narrow connection remains, the baby won’t show symptoms. If the connection is larger, the baby may be breathless and tired and show poor weight gain.
4.5. Tetralogy of fallot
A small percentage of babies with Down syndrome have this complex heart condition which combines the most common defect associated with Down syndrome, AVSD, with Tetralogy of fallot.
This anomaly includes four different heart problems:
A hole between the top chambers and a hole between the bottom chambers
Combined mitral and tricuspid valves (common atrioventricular valve)
Narrowed pulmonary artery (from heart to lungs) or the area under or above the valve, or all three
Thickening of the right bottom chamber (ventricle)
The combination of these defects early in life almost seems to balance out such that the child may be rather blue, but not too breathless. There can, of course, be too much blueness or too much breathlessness, depending on the severity of the different conditions.
In Tetralogy of fallot (TOF), often caynosis is not present at birth but increasing hypertrophy of the right ventricular infundibulum and cyanosis occur usually in the later part of infancy. But cyanosis is present since birth if Tetralogy of Fallot is accompanied with Down Syndrome. This may be due to increased hypertrophy of the right ventricular infundibulum in patient of TOF with DS at birth. (AKMM Rashid et al., 2009)
5. Case
A case of eleven months boy was admitted in a hospital with the complaints of bluish discoloration of lip and finger since birth and low grade fever, cough for seven days. Bluish discoloration aggravates during crying. He was born to an elderly mother and was completely immunized. There was no such illness in the family. On examination the child was cyanosed, heart rate 130/m, weight 7.5 kg. He had got mongoloid face with flat occiput, depressed nasal bridge, upward slanting of eyes, medial epicanthic fold. There was gap between the first and second toes with clinodactyly. On examination of the precordium there was left parasternal heave, pansystolic murmur was present in the lower sternal border. There was motor developmental delay. The boy was clinically diagnosed with congenital cyanotic heart disease with Down syndrome. On investigation his hemoglobin was 78%, Total leucocyte count 14700/cum, Neutrophil 82%, X – Ray chest had the feature of boot shaped cardiac shadow. ECG showed right ventricular hypertrophy. Karyotyping showed trisomy 21. Tetralogy of fallot was detected by Echocardiogram. Finally the child was diagnosed as Down Syndrome with Tetralogy of Fallot. (AKMM Rashid et al., 2009)
Figure 1.
Patient with Down syndrome.
Figure 2.
Echocardiogram showing Tetralogy of Fallot.
Figure 3.
X-ray chest showing : boot shaped heart.
6. Other heart related problems in Down syndrome
In addition to the heart defects associated with Down syndrome, high blood pressure in the lungs (pulmonary hypertension) is more common in people with Down syndrome. This high blood pressure may be a result of malformation of the lung tissue, but the exact cause is not known. High blood pressure may limit the amount of blood flow to the lungs and therefore decrease the likelihood of symptoms of congestive heart failure seen in babies with complete AV canals or large ventricular septal defects.
7. Diagnosis
All babies that have been diagnosed with Down syndrome should have a cardiology evaluation because of the high incidence of associated congenital heart defects. A good history and physical examination should be performed in all Down syndrome children to rule out any obvious heart defect. Early diagnosis of congenital heart disease particularly of large left to right shunts, could enable a paediatrician to follow the baby carefully, to start medical treatment with diuretics and digoxin at an earlier stage and possibly to plan for earlier surgical intervention should this be indicated. Babies should be seen as early in life as possible, preferably in the first six months of life before pulmonary vascular disease can develop.
Electocardiogram can be very helpful in making the diagnosis of AV canal defect, even in the absence of physical findings.(Shashi V et al., 2002)
Echocardiography has to be performed routinely early in life in Down syndrome can detect congenital heart disease that might otherwise be missed. Early detection may help prevent complications such as pulmonary vascular disease that may adversely affect the outcome of cardiac surgery.
Occasionally a repeat electrocardiogram, chest x-ray, or echocardiogram is performed to further evaluate clinical changes. These tests are likely to be repeated before surgical repair is recommended.
Rarely, a cardiac catheterization is required for complete evaluation prior to corrective surgery especially in patients where elevated pressures in the lungs are a concern.
8. Treatment
Children with Down syndrome and symptoms of congestive heart failure can be initially managed medically with the use of diuretics, blood pressure medications to allow the heart to eject more blood out to the body rather than out to the lungs; and/or digoxin, a medication and to improve the pumping ability of the heart.
If the baby is having difficulty with feeding and weight gain, nasogastric tube feeding with calorie formula or fortified breast milk can be used to help with growth.
These are all temporary solutions to allow the baby to grow while deciding if and when surgery is indicated. If the baby has no signs of heart failure or is controlled well with medications, the decisions for surgical closure can be delayed. The decision must be individualized to each child’s physical state as well as the family’s concerns. The majority of cases of AVSD usually require surgical intervention; this generally takes place within the first six months of life.
Many VSD, will close spontaneously or get much smaller, so, it is normal practice to leave a child with a small or moderate VSD and monitor their progress before deciding to operate. Surgery may be needed if there is failure to thrive despite medication, or concern about pulmonary hypertension. If a large VSD is present, surgery is almost always recommended.
Small holes in ASD which allows little blood flow from left to right generally causes no problems. If they are located in the middle portion of the central heart wall, they may even close on their own. However, moderate and large holes do not close, and the extra work over the years places a strain of the right side of the heart causing an enlargement of both pumping chambers. Therefore, Surgery is recommended in the first few years of life or larger holes, before excessive strain has been placed on the heart.
If the ductus open for more than three months, it is unlikely to close on its own and surgical closure is imperative.
The types of surgery in TOF depend on the severity of the AVSD or the Fallots. Usually the children are quite blue and require a BT shunt to increase the amount of blue going to the lungs. Then another operation is performed later- usually at 1-2 years of age- so, that the holes can be closed, the valves repaired and the way out to the lung artery widened. (Cincinnati Children’s hospital medical Center, 2006)
9. Long-term outlook
Over all, survival beyond one year of age is 85 percent in all children with Down syndrome. Over 50 percent of individuals with Down syndrome live to be greater than 50 years of age.
Congenital heart disease is the most common causes of death in early childhood. However, as of the late 1980s, 70 percent of children with Down syndrome and congenital heart disease lived beyond their first birth day with improved medical and surgical care, these numbers continue to improve. (Cincinnati Children’s hospital medical Center, 2009)
Abbreviation
ASD – Atrial Septal Defect
AVSD- Atrioventricular Septal Defect
BAC- Beta-site APP –Cleaving
CHD- Congenital Heart Disease
DSCAM- Down syndrome cell adhesion molecule
DS- Down syndrome
MX- Myxovirus resistance
PDA- Patent Ductus Arteriosus
PFKL- Phosphofructo-kinase liver types
TOF- Tetralogy of fallot
VSD-Ventricular Septal defect
BT- Blalock Taussig
\n',keywords:null,chapterPDFUrl:"https://cdn.intechopen.com/pdfs/43380.pdf",chapterXML:"https://mts.intechopen.com/source/xml/43380.xml",downloadPdfUrl:"/chapter/pdf-download/43380",previewPdfUrl:"/chapter/pdf-preview/43380",totalDownloads:2280,totalViews:1034,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,dateSubmitted:"April 25th 2012",dateReviewed:"August 13th 2012",datePrePublished:null,datePublished:"March 6th 2013",dateFinished:null,readingETA:"0",abstract:null,reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/43380",risUrl:"/chapter/ris/43380",book:{slug:"down-syndrome"},signatures:"A. K. M. Mamunur Rashid",authors:[{id:"156647",title:"Dr.",name:"A K M Mamunur",middleName:null,surname:"Rashid",fullName:"A K M Mamunur Rashid",slug:"a-k-m-mamunur-rashid",email:"mamunkmc@yahoo.com",position:null,institution:{name:"Khulna Medical College",institutionURL:null,country:{name:"Bangladesh"}}}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Etiology and genetics",level:"1"},{id:"sec_3",title:"3. Type of heart defects in children with Down syndrome",level:"1"},{id:"sec_4",title:"4. Presentations",level:"1"},{id:"sec_4_2",title:"4.1. Atroventricular Septal Defects (AVSDs)",level:"2"},{id:"sec_5_2",title:"4.2. Ventricular Septal Defects (VSDs)",level:"2"},{id:"sec_6_2",title:"4.3. Atrial Septal Defects (ASDs)",level:"2"},{id:"sec_7_2",title:"4.4. Patent Ductus Anteriosus (PDA)",level:"2"},{id:"sec_8_2",title:"4.5. Tetralogy of fallot",level:"2"},{id:"sec_10",title:"5. Case",level:"1"},{id:"sec_11",title:"6. Other heart related problems in Down syndrome",level:"1"},{id:"sec_12",title:"7. Diagnosis",level:"1"},{id:"sec_13",title:"8. Treatment",level:"1"},{id:"sec_14",title:"9. Long-term outlook",level:"1"},{id:"sec_15",title:"Abbreviation",level:"1"}],chapterReferences:[{id:"",body:"AKM Mamunur Rashid, Biswajit Basu, Md. Mizanur Rahman. Tetralogy of Fallot in Down syndrome (Trisomy 21)- An uncommon association. Pak J Med Sci, 2009 vol. 25, no.4, 698-700."},{id:"",body:"Anderson RH. Simplifying the understanding of congenital malformations of the heart. Int J Cardiol 1991; 32: 131-42."},{id:"",body:"Barlow G M., Xiao-Ning Chen, Zheng Y. Shi, Gary E Lyons, David M. Kurnit, Livija Celle, Nancy B. Spinner, Elaine Zackai, Mark J. Pettenati, Alexander J. Van Riper, Michael J. Vekemans, Corey H. Mjaatvedt, Julie R Korenberg. Genetics in Medicine March/April 2001-Vol.3, No.2, 91-101. "},{id:"",body:"Behrman RE, Kliegman RM and Jenson HB. From congenital heart disease. Philadelphia: Harcourt Asia Pvt. Ltd. Nelson Textbook of Pediatrics. 2000; 16 1362-63."},{id:"",body:"Berr C and Borghi E. Risk of Down syndrome in relatives of trisomy 21 children. A case-control study. Ann Genet 1990;33:137-40."},{id:"",body:"Cooney TP, Thurlbeck WM. Pulmonary hypoplasia in Down’s syndrome. N Engl J Med 1982; 307: 1170-73."},{id:"",body:"Cincinnati Children’s hospital medical Center. Heart- Related Syndrome (Trisomy 21). 2006 :1-4. www.cincinnatichildrens.org/health/heart-encyclopedia/anomalies/pda"},{id:"",body:"Cincinnati Children’s hospital medical Center. Down Syndrome (Trisomy 21). 2009:1-4. www.cincinnatichildrens.org/health/d/down"},{id:"",body:"Delabar JM, Theophile D, Rahmani Z, Chettouh Z, Blouin JL, Preiur M,Noel B, Sinet PM. Molecular mapping of 24 features of Down syndrome on chromosome 21.Eur J Hum Genet 1993; 1: 114-24."},{id:"",body:"Du ZD, Roguin N, Barak M, Bihari SG, Ben-Elisha M. High prevalence of muscular ventricular septal defect in preterm neonates. Am J Cardiol. 1996; 78: 1183-85."},{id:"",body:"Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD, , editors. Perspective in pediatric cardiology. Vol 5. Armonk NY: The Baltimore-Washington infant study, 1997."},{id:"",body:"Francis F, Lehrach H, Reinhardt R, Yaspo MI. The DNA sequence of human chromosome 21. Nature 2000; 405: 311-19."},{id:"",body:"Hubert RS, Mitchell S, Chen X-N, Ekmekji K, Gadomski C, Sun Z, Noya D, Kim U-J, Chen C, Shizuya H, Simon M, de jong PJ, Korenberg JR. BAC and PAC contigs covering 3.5 Mb of the down syndrome congenital heart disease region between D21S55 and MX1 on chromosome 21. Genomics 1997; 41: 218-26."},{id:"",body:"Hattori M, Fujiyama A, Taylor TD, Watanabe H, Yada T, Park HS, Toyoda A, Ishii K, Totoki Y, Choi DK, Soeda E, Ohki M, Takagi T, Sakaki T, Taudien S, Blechschmidt K, Polley A, Menzel U, Delabar J, Kumpf K, Lehmann R, Patterson D, Reichwald K, Rump A, Schillhabel M, Schudy A, Zimmermann W, Rosenthal A, Kudoh J, Shibuya K, Kawasaki K, Asakawa S, Shintani A, Sasaki T, Nagamine K, Mitsuyama S, Antonarakis SE, Minoshima S, Shimizu N, Nordsick G, Hornischer K, Bendt P, Scharfe M, Schn O, Desario A, Reichelt J, Kaur G, Blocker H, Ramser J, Beck A, Klages S, Hennig S, Rielssenmann I, Dagand F, Haaf T, wehrmeyer S, Borzym K, Gardiner k, Nizetic D, Francis F, Lehrach H, Reirhardt R, Yas Po MI. The DNA sequence of human chromosome 21. Nature 2000;405:311-19. "},{id:"",body:"Hassold TA, and Sherman S. Down syndrome; Genetic recombination and origin of the extra chromosome 21. Clin Genet, 2000; 57: 95-100."},{id:"",body:"Hoffman JI. Congenital heart disease: incidence and inheritance. Pediatr Clin North Am. 1990; 37: 25-43."},{id:"",body:"Hoffman JI, Kaplan S, Liberthson RR. Prevalence of congenital heart disease. Am Heart J. 2004; 147: 425-39."},{id:"",body:"Korenberg JR, Kawashima H, Pulst SM, Ikeuchi T, Ogasawara SA, Yamatoto K, Schonberg SA. Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. Am J Hum Genet 1990; 47: 236-46."},{id:"",body:"Korenberg JR, Bradley C, Disteche C. Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis. Am J Hum Genet 1992; 50: 294-302."},{id:"",body:"Korenberg JR, Chen X-N, Schipper R, Sun Z, Gonsky RGerwehr S, Carpenter N, Daumer C, Dignan P, Disteche C, Graham JM, Hudgins L, McGiillivray B, Miyazaki K, Ogasawara N, Park JP, Pagon R, Pueschel S, Sack G, Say B, Schuffenhaur S, Soukup S, Yamanaka T. Down symdrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci U S A 1994;91:4997-5001."},{id:"",body:"Moller JH, Allen HD, Clerk EB, Dajani AS, Golden A, Hayman LL, Lauer RM, Marmer EL, McAnulty JH, Oparil S. Report of the task force on children and youth: American heart association. Circulation. 1993; 88: 2479-86."},{id:"",body:"McCormick MK, Schinzel A, Petersen MB, Stetten G, Driscoll DJ, Cantu ES,Tranebjaerg L, Mikkelsen M, Watkins PC, Antonarakis SE. Molecular genetic approach to the characterization of the” Down syndrome region” of chromosome 21. Genomics 1989; 5: 325-31."},{id:"",body:"Payne M, Johnson MC, Grant JW, and Strauss AW. 1995. Towards a molecular understanding of congenital heart disease . Circulation. 91: 494-504. "},{id:"",body:"Piperpont ME, Craig T, Basson D, Benson W, Jr. Bruce DG, Giglia TM, Goldmuntz E, McGee G, Craig A Sable, Srivastava D, and Catherine L. Webb. Genetic Basis for Congenital Heart Defects: Current Knowledge: Circulation 2007; 115: 3015-3038. "},{id:"",body:"Rahmani Z, Blouin JI, Creau-Goldberg N Watkins PC, Mattei JF, Poissonnier M,Prieur M, Chettouh Z, Nicole A, Aurias A, Sinet P, Delabar J.Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome. Proc Natl Acad Sci U S A 1989; 86: 5958-62."},{id:"",body:"Ramakrishnan V. Research Article: Genetic aspects of congenital heart disease in Down syndrome. Inter J Cur Res 2011; 3(6): 165-70."},{id:"",body:"Roguin N, Du ZD, Barak M, Nasser N, hershkowitz S, Milgram E. High prevalence of muscular ventricular septal defect in neonates. J Am Coll Cardiol. 1995; 26: 1545-48."},{id:"",body:"Rodriguez LH, and Reyes JN. Cardiopatias en el syndrome de Down. Bol Med Hosp Infant Mex. 1984; 41: 622-25."},{id:"",body:"Shashi V, Berry MN, Covitz W. A combination of physical examination and ECG detects the majority of hemodynamically significant heart defects in neonates with Down syndrome. Am J Med Genet 2002 Mar 15;108(3):205-8."},{id:"",body:"Stoll C, Alembik Y, Dott B, Roth MP. 1998. Study of Down syndrome in 238,942 consecutive births. Ann Genet. 41: 44-51."},{id:"",body:"T R J Tubman, M D Shields, B G Craig, H C Mulholland, N c Nevin. Congenital Heart Disease in Down syndrome; two year prospective early screening study. B M J, Volume 302, 15 June, 1991, 1425-27."},{id:"",body:"Van Praagh R, Papagiannis J, Bar-EI YI, Schwint OA. The heart in Down syndrome: Pathologic anatomy. In: Marino B, Pueschel SM, editors. Heart disease in persons with Down syndrome. Baltimore, MD: Paul H Brookers Publishing Co. 1996: 69-110."},{id:"",body:"Yamakawa K, Huo YK, Haendelt MA, Hubert R, Chen X-N, Lyones GE, Korenberg JR. DSCAM: a novel member of the immunoglobulin super family maps in a Down syndrome region and is involved in the development of the nervous system. Hum Mol Genet 1998; 7: 227-37."}],footnotes:[],contributors:[{corresp:null,contributorFullName:"A. K. M. Mamunur Rashid",address:null,affiliation:'
Dept. of Pediatrics, Khulna Medical College, Khulna, Bangladesh
'}],corrections:null},book:{id:"3298",title:"Down Syndrome",subtitle:null,fullTitle:"Down Syndrome",slug:"down-syndrome",publishedDate:"March 6th 2013",bookSignature:"Subrata Kumar Dey",coverURL:"https://cdn.intechopen.com/books/images_new/3298.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"31178",title:"Prof.",name:"Subrata",middleName:"Kumar",surname:"Dey",slug:"subrata-dey",fullName:"Subrata Dey"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"43371",title:"Down Syndrome: Clinical and Genetic Aspects, Genetic Counseling and Prenatal Screening and Diagnosis",slug:"down-syndrome-clinical-and-genetic-aspects-genetic-counseling-and-prenatal-screening-and-diagnosis",totalDownloads:2639,totalCrossrefCites:0,signatures:"Érika Cristina Pavarino, Joice Matos Biselli, Walter Pinto Junior and Eny Maria Goloni Bertollo",authors:[{id:"34736",title:"Prof.",name:"Érika Cristina",middleName:null,surname:"Pavarino",fullName:"Érika Cristina Pavarino",slug:"erika-cristina-pavarino"},{id:"45453",title:"MSc.",name:"Joice Matos",middleName:null,surname:"Biselli",fullName:"Joice Matos Biselli",slug:"joice-matos-biselli"},{id:"45454",title:"Prof.",name:"Eny Maria",middleName:null,surname:"Goloni Bertollo",fullName:"Eny Maria Goloni Bertollo",slug:"eny-maria-goloni-bertollo"},{id:"166057",title:"Dr.",name:"Walter",middleName:null,surname:"Pinto Júnior",fullName:"Walter Pinto Júnior",slug:"walter-pinto-junior"}]},{id:"41379",title:"Increased Fetal Nuchal Translucency Thickness and Normal Karyotype: Prenatal and Postnatal Outcome",slug:"increased-fetal-nuchal-translucency-thickness-and-normal-karyotype-prenatal-and-postnatal-outcome",totalDownloads:10184,totalCrossrefCites:1,signatures:"Ksenija Gersak, Darija M. Strah and Maja Pohar-Perme",authors:[{id:"53853",title:"Prof.",name:"Ksenija",middleName:null,surname:"Gersak",fullName:"Ksenija Gersak",slug:"ksenija-gersak"},{id:"88543",title:"Dr.",name:"Maja",middleName:null,surname:"Pohar-Perme",fullName:"Maja Pohar-Perme",slug:"maja-pohar-perme"},{id:"88544",title:"M.D.",name:"Darija",middleName:"Mateja",surname:"Strah",fullName:"Darija Strah",slug:"darija-strah"}]},{id:"43372",title:"Prenatal Screening and Diagnosis",slug:"prenatal-screening-and-diagnosis",totalDownloads:2058,totalCrossrefCites:0,signatures:"Jaana Marttala",authors:[{id:"162693",title:"Ph.D.",name:"Jaana",middleName:null,surname:"Marttala",fullName:"Jaana Marttala",slug:"jaana-marttala"}]},{id:"42625",title:"Control of Dental Biofilm and Oral Health Maintenance in Patients with Down Syndrome",slug:"control-of-dental-biofilm-and-oral-health-maintenance-in-patients-with-down-syndrome",totalDownloads:1950,totalCrossrefCites:0,signatures:"Ana Paula Teitelbaum and Gislaine Denise Czlusniak",authors:[{id:"158011",title:"Dr",name:"Gislaine",middleName:null,surname:"Czlusniak",fullName:"Gislaine Czlusniak",slug:"gislaine-czlusniak"},{id:"158012",title:"Dr.",name:"Ana Paula",middleName:null,surname:"Teitelbaum",fullName:"Ana Paula Teitelbaum",slug:"ana-paula-teitelbaum"}]},{id:"43373",title:"How to Design an Exercise Program TO Reduce Inflammation in Obese People With Down Syndrome",slug:"how-to-design-an-exercise-program-to-reduce-inflammation-in-obese-people-with-down-syndrome",totalDownloads:1247,totalCrossrefCites:0,signatures:"Francisco J. Ordonez, Gabriel Fornieles, Alejandra Camacho, Miguel A. Rosety, Antonio J Diaz, Ignacio Rosety, Natalia Garcia and Manuel Rosety-Rodriguez",authors:[{id:"156546",title:"Dr",name:"Francisco Javier",middleName:null,surname:"Ordonez",fullName:"Francisco Javier Ordonez",slug:"francisco-javier-ordonez"}]},{id:"43380",title:"Heart Diseases in Down Syndrome",slug:"heart-diseases-in-down-syndrome",totalDownloads:2280,totalCrossrefCites:0,signatures:"A. K. M. Mamunur Rashid",authors:[{id:"156647",title:"Dr.",name:"A K M Mamunur",middleName:null,surname:"Rashid",fullName:"A K M Mamunur Rashid",slug:"a-k-m-mamunur-rashid"}]},{id:"43381",title:"Myeloid Leukemia Associated with Down Syndrome",slug:"myeloid-leukemia-associated-with-down-syndrome",totalDownloads:1907,totalCrossrefCites:0,signatures:"Kazuko Kudo",authors:[{id:"155649",title:"Dr.",name:"Kazuko",middleName:null,surname:"Kudo",fullName:"Kazuko Kudo",slug:"kazuko-kudo"}]},{id:"43385",title:"Molecular Pathways of Down Syndrome Critical Region Genes",slug:"molecular-pathways-of-down-syndrome-critical-region-genes",totalDownloads:1945,totalCrossrefCites:1,signatures:"Ferdinando Di Cunto and Gaia Berto",authors:[{id:"157492",title:"Prof.",name:"Ferdinando",middleName:null,surname:"Di Cunto",fullName:"Ferdinando Di Cunto",slug:"ferdinando-di-cunto"},{id:"158844",title:"Dr.",name:"Gaia",middleName:null,surname:"Berto",fullName:"Gaia Berto",slug:"gaia-berto"}]},{id:"43386",title:"Risk Factors for Down Syndrome Birth: Understanding the Causes from Genetics and Epidemiology",slug:"risk-factors-for-down-syndrome-birth-understanding-the-causes-from-genetics-and-epidemiology",totalDownloads:2897,totalCrossrefCites:1,signatures:"Sujay Ghosh and Subrata Kumar Dey",authors:[{id:"31178",title:"Prof.",name:"Subrata",middleName:"Kumar",surname:"Dey",fullName:"Subrata Dey",slug:"subrata-dey"},{id:"125697",title:"Prof.",name:"Sujoy",middleName:null,surname:"Ghosh",fullName:"Sujoy Ghosh",slug:"sujoy-ghosh"}]},{id:"42500",title:"RCAN1 and Its Potential Contribution to the Down Syndrome Phenotype",slug:"rcan1-and-its-potential-contribution-to-the-down-syndrome-phenotype",totalDownloads:1531,totalCrossrefCites:1,signatures:"Melanie A. Pritchard and Katherine R. Martin",authors:[{id:"156218",title:"Dr.",name:"Melanie",middleName:null,surname:"Pritchard",fullName:"Melanie Pritchard",slug:"melanie-pritchard"}]},{id:"43392",title:"Laterality Explored: Atypical Hemispheric Dominance in Down Syndrome",slug:"laterality-explored-atypical-hemispheric-dominance-in-down-syndrome",totalDownloads:1642,totalCrossrefCites:1,signatures:"George Grouios, Antonia Ypsilanti and Irene Koidou",authors:[{id:"39181",title:"Prof.",name:"George",middleName:null,surname:"Grouios",fullName:"George Grouios",slug:"george-grouios"},{id:"45480",title:"Dr.",name:"Antonia",middleName:null,surname:"Ypsilanti",fullName:"Antonia Ypsilanti",slug:"antonia-ypsilanti"},{id:"162500",title:"Prof.",name:"Irene",middleName:null,surname:"Koidou",fullName:"Irene Koidou",slug:"irene-koidou"}]},{id:"43394",title:"Genetic and Epigenetic Mechanisms in Down Syndrome Brain",slug:"genetic-and-epigenetic-mechanisms-in-down-syndrome-brain",totalDownloads:2061,totalCrossrefCites:8,signatures:"Jie Lu and Volney Sheen",authors:[{id:"40911",title:"Dr.",name:"Volney",middleName:null,surname:"Sheen",fullName:"Volney Sheen",slug:"volney-sheen"},{id:"47427",title:"Dr.",name:"Jie",middleName:null,surname:"Lu",fullName:"Jie Lu",slug:"jie-lu"}]}]},relatedBooks:[{type:"book",id:"211",title:"Genetics and Etiology of Down Syndrome",subtitle:null,isOpenForSubmission:!1,hash:"25b79c06f3fee34858efd200dd285ca6",slug:"genetics-and-etiology-of-down-syndrome",bookSignature:"Subrata Dey",coverURL:"https://cdn.intechopen.com/books/images_new/211.jpg",editedByType:"Edited by",editors:[{id:"31178",title:"Prof.",name:"Subrata",surname:"Dey",slug:"subrata-dey",fullName:"Subrata Dey"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"18436",title:"Genetics of Down Syndrome",slug:"genetics-of-down-syndrome",signatures:"Thomas Eggermann and Gesa Schwanitz",authors:[{id:"29551",title:"Prof.",name:"Thomas",middleName:null,surname:"Eggermann",fullName:"Thomas Eggermann",slug:"thomas-eggermann"},{id:"40492",title:"Prof.",name:"Gesa",middleName:null,surname:"Schwanitz",fullName:"Gesa Schwanitz",slug:"gesa-schwanitz"}]},{id:"18437",title:"Etiology of Down Syndrome: Risk of Advanced Maternal Age and Altered Meiotic Recombination for Chromosome 21 Nondisjunction",slug:"etiology-of-down-syndrome-risk-of-advanced-maternal-age-and-altered-meiotic-recombination-for-chromo",signatures:"Subrata Kumar Dey and Sujoy Ghosh",authors:[{id:"31178",title:"Prof.",name:"Subrata",middleName:"Kumar",surname:"Dey",fullName:"Subrata Dey",slug:"subrata-dey"},{id:"125697",title:"Prof.",name:"Sujoy",middleName:null,surname:"Ghosh",fullName:"Sujoy Ghosh",slug:"sujoy-ghosh"}]},{id:"18438",title:"Combinatorial Gene Effects on the Neural Progenitor Pool in Down Syndrome",slug:"combinatorial-gene-effects-on-the-neural-progenitor-pool-in-down-syndrome",signatures:"Jie Lu and Volney Sheen",authors:[{id:"40911",title:"Dr.",name:"Volney",middleName:null,surname:"Sheen",fullName:"Volney Sheen",slug:"volney-sheen"},{id:"47427",title:"Dr.",name:"Jie",middleName:null,surname:"Lu",fullName:"Jie Lu",slug:"jie-lu"}]},{id:"18439",title:"Down Syndrome: A Complex and Interactive Genetic Disorder",slug:"down-syndrome-a-complex-and-interactive-genetic-disorder",signatures:"Samantha L. Deitz, Joshua D. Blazek, Jeffrey P. Solzak and Randall J. Roper",authors:[{id:"31505",title:"Dr.",name:"Randall J.",middleName:null,surname:"Roper",fullName:"Randall J. Roper",slug:"randall-j.-roper"},{id:"45540",title:"Ms.",name:"Samantha L.",middleName:null,surname:"Deitz",fullName:"Samantha L. Deitz",slug:"samantha-l.-deitz"},{id:"45541",title:"Mr.",name:"Joshua D.",middleName:null,surname:"Blazek",fullName:"Joshua D. Blazek",slug:"joshua-d.-blazek"},{id:"45542",title:"Mr.",name:"Jeffrey P.",middleName:null,surname:"Solzak",fullName:"Jeffrey P. Solzak",slug:"jeffrey-p.-solzak"}]},{id:"18440",title:"Abnormal Folate Metabolism and Maternal Risk for Down Syndrome",slug:"abnormal-folate-metabolism-and-maternal-risk-for-down-syndrome",signatures:"Érika Cristina Pavarino, Bruna Lancia Zampieri, Joice Matos Biselli and Eny Maria Goloni Bertollo",authors:[{id:"34736",title:"Prof.",name:"Érika Cristina",middleName:null,surname:"Pavarino",fullName:"Érika Cristina Pavarino",slug:"erika-cristina-pavarino"},{id:"45452",title:"MSc.",name:"Bruna Lancia",middleName:null,surname:"Zampieri",fullName:"Bruna Lancia Zampieri",slug:"bruna-lancia-zampieri"},{id:"45453",title:"MSc.",name:"Joice Matos",middleName:null,surname:"Biselli",fullName:"Joice Matos Biselli",slug:"joice-matos-biselli"},{id:"45454",title:"Prof.",name:"Eny Maria",middleName:null,surname:"Goloni Bertollo",fullName:"Eny Maria Goloni Bertollo",slug:"eny-maria-goloni-bertollo"}]},{id:"18441",title:"Down Syndrome Expressed Protein; DSCR-1 Deters Cancer and Septic Inflammation",slug:"down-syndrome-expressed-protein-dscr-1-deters-cancer-and-septic-inflammation",signatures:"Takashi Minami",authors:[{id:"41267",title:"Prof.",name:"Takashi",middleName:null,surname:"Minami",fullName:"Takashi Minami",slug:"takashi-minami"}]},{id:"18742",title:"Down Syndrome and Vascular Disease: DSCR1 and NFAT Signaling",slug:"down-syndrome-and-vascular-disease-dscr1-and-nfat-signaling",signatures:"Monica Y. Lee and Brian R. Wamhoff",authors:[{id:"47765",title:"Dr.",name:"Brian R.",middleName:null,surname:"Wamhoff",fullName:"Brian R. Wamhoff",slug:"brian-r.-wamhoff"},{id:"102751",title:"Dr.",name:"Monica Y.",middleName:null,surname:"Lee",fullName:"Monica Y. Lee",slug:"monica-y.-lee"}]},{id:"18443",title:"Down Syndrome Model of Alzheimer’s Disease: Beyond Trisomy 21Nondisjunction",slug:"down-syndrome-model-of-alzheimer-s-disease-beyond-trisomy-21nondisjunction",signatures:"Antoneta Granic and Huntington Potter",authors:[{id:"60528",title:"Dr.",name:"Huntington",middleName:null,surname:"Potter",fullName:"Huntington Potter",slug:"huntington-potter"}]},{id:"18444",title:"Deficiency of Adult Neurogenesis in the Ts65Dn Mouse Model of Down Syndrome",slug:"deficiency-of-adult-neurogenesis-in-the-ts65dn-mouse-model-of-down-syndrome",signatures:"Pavel V. Belichenko and Alexander M. Kleschevnikov",authors:[{id:"58261",title:"Prof.",name:"Pavel V.",middleName:"V.",surname:"Belichenko",fullName:"Pavel V. Belichenko",slug:"pavel-v.-belichenko"},{id:"92944",title:"Prof.",name:"Alexander M.",middleName:"M.",surname:"Kleschevnikov",fullName:"Alexander M. Kleschevnikov",slug:"alexander-m.-kleschevnikov"}]},{id:"18445",title:"Dermatological Manifestations of Down Syndrome",slug:"dermatological-manifestations-of-down-syndrome",signatures:"Dominguez-Cruz JJ and Bueno Delgado MA",authors:[{id:"34530",title:"Dr.",name:"JJ",middleName:null,surname:"Domingues-Cruz",fullName:"JJ Domingues-Cruz",slug:"jj-domingues-cruz"},{id:"42594",title:"Dr.",name:"Maria",middleName:null,surname:"Bueno-Delgado",fullName:"Maria Bueno-Delgado",slug:"maria-bueno-delgado"}]},{id:"18446",title:"Down Syndrome and Periodontal Disease",slug:"down-syndrome-and-periodontal-disease",signatures:"Ahmed Khocht",authors:[{id:"28156",title:"Dr.",name:"Ahmed",middleName:null,surname:"Khocht",fullName:"Ahmed Khocht",slug:"ahmed-khocht"}]},{id:"18447",title:"Dysfunctional Voiding of Non-Neurogenic Neurogenic Bladder: A Urological Disorder Associated with Down Syndrome",slug:"dysfunctional-voiding-of-non-neurogenic-neurogenic-bladder-a-urological-disorder-associated-with-dow",signatures:"Narihito Seki and Nouval Shahab",authors:[{id:"45119",title:"Dr.",name:"Narihito",middleName:null,surname:"Seki",fullName:"Narihito Seki",slug:"narihito-seki"},{id:"47146",title:"Dr.",name:"Nouval",middleName:null,surname:"Shahab",fullName:"Nouval Shahab",slug:"nouval-shahab"}]},{id:"18448",title:"Down Syndrome and Epilepsy",slug:"down-syndrome-and-epilepsy",signatures:"A. Nascimento and C. Ortez-González",authors:[{id:"31072",title:"Dr.",name:"Carlos",middleName:null,surname:"Ortez-González",fullName:"Carlos Ortez-González",slug:"carlos-ortez-gonzalez"},{id:"44771",title:"Dr.",name:"Andrés",middleName:null,surname:"Nascimento",fullName:"Andrés Nascimento",slug:"andres-nascimento"}]},{id:"18743",title:"Endocrine and Autonomic Nervous Adaptations during Physical Exercise in Down Syndrome",slug:"endocrine-and-autonomic-nervous-adaptations-during-physical-exercise-in-down-syndrome",signatures:"Véronique ~ Aurélie Bricout",authors:[{id:"29316",title:"Dr.",name:"Véronique-Aurelie",middleName:null,surname:"Bricout",fullName:"Véronique-Aurelie Bricout",slug:"veronique-aurelie-bricout"}]},{id:"18744",title:"Language and Visuospatial Abilities in Down Syndrome Phenotype: A Cognitive Neuroscience Perspective",slug:"language-and-visuospatial-abilities-in-down-syndrome-phenotype-a-cognitive-neuroscience-perspective",signatures:"George Grouios and Antonia Ypsilanti",authors:[{id:"39181",title:"Prof.",name:"George",middleName:null,surname:"Grouios",fullName:"George Grouios",slug:"george-grouios"},{id:"45480",title:"Dr.",name:"Antonia",middleName:null,surname:"Ypsilanti",fullName:"Antonia Ypsilanti",slug:"antonia-ypsilanti"}]},{id:"18451",title:"Prenatal Diagnosis of Down Syndrome",slug:"prenatal-diagnosis-of-down-syndrome",signatures:"Myungshin Kim, Jong Chul Shin and In Yang Park",authors:[{id:"28289",title:"Dr.",name:"Myungshin",middleName:null,surname:"Kim",fullName:"Myungshin Kim",slug:"myungshin-kim"},{id:"43194",title:"Prof.",name:"Jong Chul",middleName:null,surname:"Shin",fullName:"Jong Chul Shin",slug:"jong-chul-shin"},{id:"43195",title:"Dr.",name:"In Yang",middleName:null,surname:"Park",fullName:"In Yang Park",slug:"in-yang-park"}]},{id:"18452",title:"First Trimester Screening for Trisomy 21 by Maternal Age, Nuchal Translucency and Fetal Nasal Bone in Unselected Pregnancies",slug:"first-trimester-screening-for-trisomy-21-by-maternal-age-nuchal-translucency-and-fetal-nasal-bone-in",signatures:"Ksenija Gersak, Maja Pohar-Perme and Darija M. Strah",authors:[{id:"53853",title:"Prof.",name:"Ksenija",middleName:null,surname:"Gersak",fullName:"Ksenija Gersak",slug:"ksenija-gersak"},{id:"88543",title:"Dr.",name:"Maja",middleName:null,surname:"Pohar-Perme",fullName:"Maja Pohar-Perme",slug:"maja-pohar-perme"},{id:"88544",title:"M.D.",name:"Darija",middleName:"Mateja",surname:"Strah",fullName:"Darija Strah",slug:"darija-strah"}]},{id:"18453",title:"Noninvasive Prenatal Nucleic Acid Diagnostics of Down Syndrome",slug:"noninvasive-prenatal-nucleic-acid-diagnostics-of-down-syndrome",signatures:"Radek Vodicka, Radek Vrtel, Jana Böhmova, Romana Kratochvilova, Ladislav Dusek, Ishraq Dhaifalah and Jiri Santavy",authors:[{id:"34497",title:"Prof.",name:"Radek",middleName:null,surname:"Vrtel",fullName:"Radek Vrtel",slug:"radek-vrtel"},{id:"42497",title:"Dr.",name:"Radek",middleName:null,surname:"Vodicka",fullName:"Radek Vodicka",slug:"radek-vodicka"},{id:"42498",title:"MSc.",name:"Jana",middleName:null,surname:"Bohmova",fullName:"Jana Bohmova",slug:"jana-bohmova"},{id:"42499",title:"BSc.",name:"Romana",middleName:null,surname:"Kratochvilova",fullName:"Romana Kratochvilova",slug:"romana-kratochvilova"},{id:"42500",title:"Dr.",name:"Ladislav",middleName:null,surname:"Dusek",fullName:"Ladislav Dusek",slug:"ladislav-dusek"},{id:"42501",title:"Prof.",name:"Jiri",middleName:null,surname:"Santavy",fullName:"Jiri Santavy",slug:"jiri-santavy"},{id:"84361",title:"Dr.",name:"Ishraq",middleName:null,surname:"Dhaifalah",fullName:"Ishraq Dhaifalah",slug:"ishraq-dhaifalah"}]}]}]},onlineFirst:{chapter:{type:"chapter",id:"71239",title:"Nature of Dark Energy",doi:"10.5772/intechopen.91442",slug:"nature-of-dark-energy",body:'
1. Introduction
The term “dark energy” refers to the cosmological constant Λ when interpreted as some kind of mysterious energy field that pervades space and exerts a negative pressure, which is the source of the observed accelerated expansion of the universe. Einstein [1] introduced the cosmological constant in 1917 to allow for a static universe but considered it a blunder after the cosmic expansion was discovered. It was only after the discovery of the accelerated expansion in the end of the 1990s through the use of supernovae type Ia as standard candles [2, 3] that it became necessary to reintroduce Λ as a fitting parameter to allow the observations to be modeled. Its physical nature has however been enigmatic and elusive. In particular the observed magnitude of Λ appears to make us “privileged observers,” because we happen to live at a time when dark energy starts to dominate over the energy densities of matter and radiation, thereby causing the onset of an inflationary phase of the universe that will continue forever. This is often referred to as the “cosmic coincidence problem.”
Dark energy is widely regarded as one of the biggest problems in contemporary physics (for a review, cf. [4]). All conceivable ways to modify gravity have been tried. Different approaches to model the observational data have been explored, e.g. [5]. Elaborate laboratory experiments have been performed in the search for new scalar fields that would modify gravity [6]. On top of this, evidence against the earlier interpretation of the supernova observations in terms of dark energy has been discovered [7].
Recently [8] it was shown that there is an alternative way to explain the need for a cosmological constant, namely, as the result of a global cosmic boundary constraint instead of through the introduction of some new physical field. This approach leads to a new cosmological framework that brings a resolution to several outstanding enigmas, including the cosmic coincidence problem. Without the use of any free parameters, Λ is predicted to have a present value that is within 2σ from the value that has been determined from CMB data with the Planck satellite [9]. The evolution of the scale factor that is derived with the new theoretical framework shows that the universe has been in a mildly accelerating, inflationary phase throughout all of the radiation-dominated era since the beginning of the Big Bang. This automatically explains the observed large-scale homogeneity and isotropy of the universe without any need to postulate a hypothetical violent inflationary phase in the grand unification theory (GUT) era of the early universe.
In Section 2 we review the arguments that have been presented in [8] for the origin of the global constraint that governs the value of Λ. These arguments depend on the participatory role of observers in the universe for the needed definition of cosmic time, with the split between past and future and the distinction between dynamic time and nonlocal (look-back) time. This will be clarified in Section 3. The mathematical equations of the new cosmological framework are derived and solved in Section 4, where we also illustrate how the cosmic evolution differs from that of standard cosmology. In Section 5 we show how inflation emerges as a natural part of cosmic history throughout the radiation-dominated era, thereby eliminating the causality problem without the assumption of any new fields. The conclusions are summarized in Section 6.
2. Resonant origin of the Λ term
In standard cosmological models, the universe is assumed to be homogeneous and isotropic on the largest scales, because this is what observations tell us. The cosmological evolution can then conveniently be described in terms of a scale factor at that only depends on time t. If we further assume zero spatial curvature, the metric can be expressed as
ds2=−c2dt2+at2dr2+r2dΩ,E1
where r is the comoving distance and dΩ is the surface element on the unit sphere. While observations show that there is no significant spatial curvature at the present epoch, there is also a theoretical justification for the validity of the flatness assumption, which emerges within the framework of the alternative cosmology of the present work. This will be clarified in Section 4.2.
Besides “proper time” t, we will need to make use of two other time concepts: “conformal time” η and “Euclidian conformal time” τ. The relation between them is defined by
dτ≡icdη≡icdt/a.E2
In terms of the temporal coordinates η and τ, the metric becomes
ds2=aη2−c2dη2+dr2+r2dΩ,ds2=aτ2dτ2+dr2+r2dΩ.E3
The conformal metric of the first of these two equations shows that the metric coefficients are proportional to ημν, the Minkowski metric: gμν=a2ημν. “Conformal” means that all angles and shapes of trigonometric functions are preserved in spite of the nonlinear temporal dependence of the scale factor a. Fourier decompositions are only meaningful within the conformal framework.
The word “Euclidian” as the term for the second metric in Eq. (3) does not refer to the flatness assumption but to the signature of the metric: (++++) instead of the (−+++) signature when using time t or η. Since the τ coordinate then formally behaves like a spatial coordinate, we have incorporated the speed of light c in the definition of τ in Eq. (2), to let τ have the dimension of space.
The transformation to Euclidian spacetime leads to remarkable advantages and insights, which have found important applications in various areas in the form of Euclidian field theory, e.g., in solid-state physics [10]. The Hamiltonian in ordinary spacetime becomes the Lagrangian in Euclidian spacetime. Quantum field theory QFT in Euclidian spacetime has the structure of statistical mechanics in ordinary spacetime. The oscillating phase factors in QFT become the Boltzmann factors, while the path integral becomes the partition function. Euclidian spacetime has long been known to provide a direct and elegant route to the derivation of the Hawking temperature of black holes, cf. [8, 11].
In the following we will show how the oscillating phase factors of the Euclidian metric field contain a resonance that fixes the value of the cosmological constant Λ. Our starting point is the Einstein equation with cosmological constant, written in the form
Rμν−Λgμν=8πGc4Tμν−12gμνT.E4
This is the appropriate form to be used with the weak-field approximation, because the right-hand side of Eq. (4) represents the source term for gravitational waves when making a Fourier expansion, while the left-hand side describes the evolution of the vacuum fields, cf. [12]. We have here adopted the standard sign convention with (−+++) for the spacetime signature and a plus sign in front of the right-hand side.
In the weak-field approximation and the harmonic gauge, Rμν≈−12∂2gμν. The d’Alembertian operator ∂2≡□2≡−1/c2∂2/∂t2+∇2. For the metrics of Eq. (3) the nabla operator in the d’Alembertian vanishes, because the spatial gradients can be disregarded on cosmological scales. The vacuum fields that represent the left-hand side of Eq. (4) then have the following weak-field representations in terms of the coordinates η and τ:
While the vacuum fields without physical sources (the Tμν fields) describe a de Sitter exponential evolution of the scale factor a when ordinary conformal time η is used as the temporal coordinate, they describe an anti-de Sitter-like universe when the τ coordinate is instead used. In this description the exponential evolution gets replaced by oscillating phase factors. To make it explicit that the τ representation leads to oscillating solutions, we have expressed it in terms of the oscillation frequency ωΛ to give it the form of the equation for a harmonic oscillator. We have divided the frequency with c in Eq. (5) to make it a wave number, because τ was defined in terms of spatial units for reasons of symmetry with respect to the other three Euclidian coordinates. Nevertheless it is more appropriate to refer to the resonance in terms of a temporal frequency ωΛ rather than a wave number, because it turns out to be related to the bounded nature of the observable timeline.
With the period of the oscillation given by ηΛ=2π/ωΛ, the relation between the cosmological constant Λ, the oscillation frequency ωΛ, and the period ηΛ, immediately follows from Eq. (5):
Λ=12ωΛ2c2=2πcηΛ2.E6
In standard cosmology Λ in Eq. (4) is generally moved to the right-hand side, where it can be interpreted as a mass-energy density ρΛ. It is convenient to describe it in terms of the dimensionless parameter ΩΛ, which is the fraction of the critical density ρc that is contributed by the Λ term:
ρΛ≡ΩΛρc=c2Λ8πG.E7
ρc represents the mean mass density that defines the boundary between open and closed model universes according to the Friedmann equations.
ρc=38πGtH2,E8
where tH=1/H is the Hubble time and H the Hubble constant.
Inserting the value of ΩΛ=0.685 determined from observations with the Planck satellite [9], we get ηΛ/tH≈3.10. As will be explicitly confirmed by the numerical solutions in Section 4, this implies a value of ηΛ that is nearly identical to the current conformal age ηu of the universe. The distance ru=cηu is the radius of the particle horizon, the maximum distance to which an observer is causally connected. ηu is the time that it would take for a photon to travel this distance if the universe would stop expanding. As the spatial points from which light is emitted continually recede from us due to the cosmic expansion, ηu is substantially larger than the “proper age” tu of the universe.
2.1 Link between Λ and the age of the universe
In standard cosmology Λ is a constant that should have nothing to do with the current age of the universe. This is contradicted by our finding that ηΛ≈ηu. Any other value would be in conflict with the observed magnitude of the cosmic acceleration. If Λ were independent of the age of the universe, then ηΛ would have been many orders of magnitude larger than ηu in the past and will be many orders of magnitude smaller in the future. It would then be an extraordinarily improbable coincidence if they happen to be the same in the present epoch. This gives us strong reasons to suspect that the value of Λ is indeed physically tied to the age ηu of the universe.
The existence of such a physical link means that we need to single out, among all the solutions of the oscillator equation in Eq. (5), the Fourier component with a wavelength that corresponds to the conformal age of the universe. This only makes sense if time is bounded between the Big Bang and the Now, which seems to contradict the Einsteinian view that all future times somehow “already preexist” and that the experienced split between past, present, and future is just a stubborn illusion. Here we will argue (for details, see Section 3) that the Einsteinian view only makes sense in a universe devoid of observers and that this is not the universe that we inhabit. Like in quantum physics the observer plays a fundamental role in defining the nature of reality. The split between past, present, and future is not some illusion that we need to come to terms with, but is deeply physical. As soon as we introduce an observer (which can be a test particle, without brains or consciousness!) in Einstein’s universe, the split occurs. In any observable universe the future does not exist, even in principle. The only accessible region is between the Big Bang and the Now, and this region is bounded. The theory has to be applied to the observable universe, not to some idealized universe without observers. This is not just some alternative philosophical viewpoint but has profound physical consequences. It leads to a very different cosmological framework, as will be made clear in the following sections.
The existence of a metric resonance with respect to Euclidian time τ implies that
gμμ∼aτ2∼e±iωuτ/c.E10
Note that the Euclidian metric and scale factor have here been treated like a quantum field by allowing them to have an analytical continuation into the complex plane. When we however convert back to ordinary conformal time η by replacing τ with icη, the oscillating phase factor transforms into an exponentially evolving factor and thereby becomes real-valued. Both exponentially decaying and increasing solutions are possible because of the ± in Eq. (10). With the initial boundary condition that the scale factor was small at early times, we can reject the decaying solution. This leaves us with the exponentially increasing de Sitter expansion of the scale factor. It is driven by the ωu resonant parameter, which can be expressed in terms of Λ via Eq. (6). It agrees with the observed value of Λ, because as found in the previous subsection, the magnitudes of ηΛ and ηu are the same.
2.2 Resonant amplitude and the validity of the weak-field approximation
According to Euclidian field theory, the oscillating QFT phase factors in Euclidian spacetime become Boltzmann factors in ordinary spacetime, if the field has periodic boundary conditions. When interpreted as due to a cosmic resonance, our finding that ηΛ≈ηu implies the existence of a periodic boundary condition with period τu in conformal Euclidian time. Euclidian field theory then allows us to make the identification
eiωuτu/c=e−ωuηu≡e−ℏωu/kBTu.E11
It gives us the temperature Tu that is induced because the time string is bounded:
Tu=ℏkBηu.E12
The identical result can be obtained with the help of Heisenberg’s uncertainty principle. For a system in thermal equilibrium at temperature T, the equipartition theorem tells us that each degree of freedom has energy 12kBT. We may therefore make the identifications
ΔE≡12kBTu,Δt≡ηu.E13
Inserting the value for Tu from Eq. (12) then gives us the Heisenberg relation
This comparison serves to demonstrate that the temperature Tu and the mode energy ℏωu both scale with 1/ηu throughout cosmic time all the way back to the Planck era. In Planck units the present age ηu of the universe is approximately 1061, which implies that the present value of Tu is only about 10−29 K. Energetically this is completely insignificant in comparison with the CMB temperature. The present mode energy ℏωu, which is about 10−61 in Planck units, represents the relative amplitude by which the metric is disturbed. As long as it is ≪1, one may use the Newtonian limit to interpret it as a potential energy and is allowed to use the weak-field approximation to describe it. The scaling shows that it remains ≪1 everywhere, except in the nonlinear regime in the immediate vicinity of the Planck era. This tells us that the weak-field approximation is valid for all times later than about 10−41s (when the amplitude was about 0.005).
2.3 Nature of the global constraint for Λ
We have shown how Λ emerges as a result of a boundary condition that exists because time in the observable universe is bounded and have referred to it as a kind of cosmic resonance. At first glance one might think that this would be some sort of cosmic Casimir effect, because the Casimir effect is known to be due to a boundary condition that limits the oscillatory modes that can exist in the quantum vacuum. Thereby measurable forces get induced.
The nature of the boundary condition is however fundamentally different in our Λ theory. The resonances of the Casimir effect are due to Dirichlet boundary conditions, when the oscillations are clamped down at the boundaries. The size of the resonant cavity is then half a wavelength, or π, for the fundamental mode. In contrast, our Λ resonance is governed by a periodic boundary condition with period 2π. Agreement with the observed value of Λ is only possible if the bounded time string has a length that corresponds to 2π. Therefore Dirichlet boundary conditions can be ruled out on observational grounds alone.
The value of Λ is tied to the value ωu of the cosmic resonance frequency. Since ωu is due to a global constraint, it is a constant that applies to all of the observable universe at the given epoch. In particular this means that ωu and Λ do not vary with redshift z, for the same kind of reason that the musical tones that emanate from a violin string are not functions of position along the string. Similarly the resonances of the wave function in atoms are represented by quantum numbers, which do not vary with position within the resonating cavity but characterize the system as a whole.
The choice of observer defines the observable universe and its age. The observer is by definition always located at redshift z=0 and experiences (and therefore also defines) local, dynamic time. In contrast, nonlocal, look-back time (for z≠0) cannot be experienced by any observer. In our theory Λ varies with dynamic time, but it does not vary with look-back time or redshift z. This implies that there is a fundamental distinction between dynamic time and look-back time, in contrast to standard cosmology. In the next section we will clarify how the boundedness of time and the distinction between local and nonlocal time is a consequence of the participatory role of observers in the universe.
3. The participatory role of observers
Although Einstein’s opinion on the split between past, present, and future seems to have been somewhat ambivalent, his most quoted statement on the subject is that this split is an illusion, “but a very stubborn one.” He tended to regard all temporal instants along the infinite timeline as somehow already preexisting as part of a 4D map. This map contains both past and future, in spite of the fact that no observer is able to directly experience any other time than what we refer to as “Now.” Nevertheless the physical meaning of the concept of “Now” remained elusive to him.
The Einsteinian view of a 4D spacetime that maps all times is meaningful only in a universe devoid of observers. As soon as one introduces an observer, the timeline automatically splits up, because the presence of an observer implies a “Here” and “Now.” This split is profoundly physical, because we know from experience that the future is not part of the observable universe. It is not accessible to any observer, even in principle. This is the only universe in which our cosmological theories can be tested, not in some idealized universe devoid of observers, to which nobody can belong.
We are not merely dealing with an alternative philosophical viewpoint, because the introduction of observers leads to a different physical theory with different testable consequences. In the observable universe, time is always bounded, between the Big Bang as one edge and the Now as the other edge. In contrast, in the Einsteinian universe, time is unbounded in the future. The finite temporal dimension allows a global boundary constraint that leads to the emergence of a Λ term in Einstein’s equations. It is the cause of the observed acceleration of the cosmic expansion.
A fundamental difference between classical and quantum physics concerns the role of observers. We can introduce test observers in classical physics, but they are not participatory in the way that they are in quantum physics. The classical world represents an objective reality that exists in a form that is independent of the presence of observers. It is the Einsteinian universe. In contrast, the quantum reality comes into existence through the participation of observers. It is the reason for the fundamental quantum fuzziness or uncertainty, the probabilistic causality, and the irreversibility through the collapse of the wave function. While the evolution of the wave function is time symmetric and deterministic, the act of “observation” or “measurement” leads to the profoundly different nature of quantum reality.
Although the role of our cosmological observers is very different from that of quantum theory, the comparison with quantum physics serves to indicate ways in which observer participation profoundly affects the nature of the theory. While abandoning the traditional classical view by allowing observer participation, we transform the theory into something that in at least this respect is closer to the nature of quantum physics. The consequence in our case is that the value of the cosmological constant gets uniquely determined in a way that leads to a very different cosmological framework.
The presence of participating observers also changes our interpretation of spacetime in a profound way by introducing a distinction between local and nonlocal time, a distinction that is absent in a universe without observers. With nonlocal time we here mean the same thing as look-back time. In contrast, dynamical time is the same as local time, because it is the only time that an observer can experience directly. The observables are redshifts, apparent brightnesses, structuring of celestial objects, etc. The observer is by definition always at redshift z=0. With the help of a cosmological model, the observables may in principle be used to infer a look-back time, which represents the way that the spacetime map appears from the vantage point of the observer.
In both standard cosmology and our alternative theory, the value of Λ applies to the totality of the observable universe at the given epoch and is therefore independent of redshift. In standard theory it is also independent of epoch (age) of the universe, while in our alternative theory, it is proportional to 1/ηu2, where ηu is the conformal age. This implies a different mathematical framework for the new cosmology, which will be developed in the next section.
4. Derivation of the cosmological evolution
The choice of observer defines the age t=tu of the universe. At proper time tu, the scale factor is au=atu, and the Hubble constant H=ȧ/a is Hu=Htu. In standard cosmology the evolution of the scale factor at, which defines the cosmological model, can be deduced from the observed relation between the expansion rate ż/1+z (Hubble constant) and the redshift z. It is then sufficient to only consider the presently observable universe. In contrast, this is not sufficient in the nonstandard cosmology that will be developed here and which we will refer to as the alternative cosmology (AC) theory in the following. The presence of the global constraint causes the nonlocal time scale (the “look-back” time when z>0) to be different from the local time scale.
The dynamical time scale is the local time scale that is experienced by a comoving observer and which characterizes the age tu of the universe. To make this distinction clear, we attach index u to all local (z=0) quantities to link them to epoch tu, i.e., to define which observable universe they refer to.
In both standard cosmology and AC theory, the expansion rate of the universe, as represented by the Hubble constant, is governed by the equation
H=HuEuz.E17
z is the redshift, and
Euz=ΩMau1+z3+ΩRau1+z4+ΩΛau1/2E18
if we assume zero spatial curvature (see Section 4.2 for a justification of this assumption). Since Hu is defined as the local Hubble constant (at z=0), it follows that ΩM+ΩR+ΩΛ=1, as required for flatness. ΩM,R,Λau represent, respectively, the matter density (including dark matter), radiation energy density, and the “dark energy” density due to the cosmological constant Λ, all in units of the critical mass-energy density. Their values in Eq. (18) refer to the epoch when the scale factor is au. The relation between ΩΛ and Λ is given by
ΩΛau=c23Hu2ΛuE19
as follows from Eqs. (7) and (8). In standard cosmology Λ does not depend on au, but in AC theory it does.
The scale factor normalized to epoch tu is
y≡a/au=1/1+z.E20
The redshifts z only have a physical meaning when they refer to an epoch tu (because this epoch is by definition where the observer at z=0 exists). In terms of parameter y, the function E in Eq. (18) becomes
Euy=ΩMauy−3+ΩRauy−4+ΩΛau1/2,E21
which satisfies the requirement of Eq. (17) that Eu=1 when y=1 or z=0.
4.1 Key difference between standard cosmology and AC theory
The values of ΩM,R,Λ that refer to the present epoch (tu=t0) can be determined by observations. In standard cosmology the parameter Λ is a true constant, independent of both redshift and epoch tu for all times. Eq. (17) then represents a differential equation that determines the complete evolution at of the scale factor, when the current values of ΩM,R,Λ are known. In contrast, in AC theory the magnitude of Λ varies with dynamical time, tracking the radius ru=cηu of the causal or particle horizon. The tracking property is governed by
Λu=2π/ru2E22
according to Eq. (6). It is the fundamental equation that sets AC theory apart from standard theory.
Because the conformal age ηu is given by an integral over all times, ΩΛ in Eq. (18) is governed by a global integral condition in AC theory. This means that the evolution of the scale factor at is obtained from the solution of an integrodifferential equation. With Eqs. (19) and (22), the relation between ΩΛ and the conformal age can be expressed in the form
ΩΛηu=23πxu2.E23
Here the dimensionless parameter xu is the conformal age in units of the Hubble time 1/Hu at the same epoch:
xu≡ηuHu.E24
4.2 Theoretical justification for the flatness assumption
While observations support our assumption of vanishing spatial curvature, AC theory requires it on theoretical grounds, in contrast to standard theory. Since curvature is induced by the presence of matter-energy sources, which may include the vacuum energy ρΛ from a cosmological constant, an empty universe without any such sources must have zero spatial curvature. In AC theory not only the matter and radiation energy densities go to zero in the distant future but also the energy density due to the Λ term. It vanishes when the horizon radius ru goes to infinity according to Eq. (22). At temporal infinity the universe is therefore empty, which implies flatness. When the curvature vanishes at a temporal boundary, it will remain zero for all other epochs. In contrast, in standard cosmology the density of “dark energy” (as represented by Λ) never vanishes but dominates the future dynamics. As the universe therefore never will be empty, the curvature is not constrained to be zero.
4.3 Iterative solution of the basic equations
Because the value of the conformal age ηu depends on the value of ΩΛ, Eq. (23) is coupled to Eq. (17) in a way that most conveniently gets solved by a straightforward iteration procedure. It is found to deliver a unique value of ΩΛ for any given value of ηu or scale factor au, without numerical complications. In particular, the solution for the present epoch is ΩΛ=67.2%, which is within 2σ from the value 68.5±0.7% that has recently been derived from observational data with the Planck satellite [9]. It would be strange if this remarkable agreement, obtained without the use of any free parameters, would merely be a fortuitous “coincidence.”
From the relation H=ȧ/a and Eq. (17), we obtain the conformal and proper ages ηu and tu. For convenience we express them in terms of the dimensionless functions xu (which was already introduced in Eqs. (23) and (24)) and gu through normalization with the Hubble time 1/Hu:
To find the xu that is needed to determine ΩΛ via the global constraint of Eq. (23), we need to know the correct Euy function to be used in Eq. (25). This function however depends on the value of ΩΛ that we want to determine. The solution can readily be obtained by iteration as follows: (i) Assume a starting value for ΩΛ, which allows Euy to be defined (as clarified below). (ii) Use this Euy function to solve Eq. (25) for xu, which can be inserted in Eq. (23) to obtain a new value for ΩΛ. Insert the result in step (i) as the new starting value, and repeat the procedure until convergence. This simple iteration procedure does not encounter any numerical problems and converges quickly.
The Eu function that is used in this iteration depends not only on the value of ΩΛ but also on the values of ΩM,Rau for the chosen epoch, which we define in terms of the value of the scale factor au=atu. The starting values of ΩM,Rau for the iteration depend on the starting value for ΩΛ, because the flatness condition ΩMau+ΩRau+ΩΛau=1 has to be satisfied. Let us next outline how these starting values are determined.
First of all, the value of ΩR for the radiation energy density is directly constrained by observations, because its value at the present epoch (au=a0=1) is fixed by the observed values of the CMB temperature and the Hubble constant H0. With the assumption of zero spatial curvature, the present value of ΩM then follows from the value of ΩΛ, because ΩM=1−ΩR+ΩΛ.
ΩR is the fraction of the critical energy density ρcc2 that is in the form of radiation energy uR (due to photons and neutrinos):
ΩR=uRρcc2,E26
where
uR=aTT41+784114/3Nν=1.681aTT4E27
cf. [13]. Nν=3 is the number of neutrino families, while T=2.725 K is the measured temperature of the cosmic microwave background, and aT is Stefan’s constant.
When going to a different epoch with a different au, we change the a/au normalization in Eq. (20) for the scale factors a and the associated redshift scale z. Then the values of ΩM and ΩR must also change, because they refer to z=0. Since ΩMρc∼au−3 while ΩRρc∼au−4, the ratio ΩR/ΩM scales as 1/au.
During the iteration we enforce the correct au scaling of the ΩRau/ΩMau ratio and the condition for spatial flatness, which together define the correct starting values for ΩMau and ΩRau, once a starting value for ΩΛau has been chosen. In the case of standard cosmology, there is no iteration, because the scaling of ΩΛ relative to ΩM,R is already known. For instance, the ratios ΩΛ/ΩM∼au3 and ΩΛ/ΩR∼au4 both imply that the Λ term was insignificant in the past but dominates in the future. In contrast, in AC theory the relative contribution of Λ does not change much throughout cosmic history. At epoch au in standard theory, ΩΛau=ΩΛ/ΩMau−3+ΩRau−4+ΩΛ, where the Ωs on the right-hand side refer to their values at the present epoch (au=a0=1). Similarly, for the matter density, we have ΩMau=ΩMau−3/ΩMau−3+ΩRau−4+ΩΛ, and correspondingly for the radiation energy density.
Besides ΩM,R,Λau, Euy, and xu, the converged iterative solution gives us gu from Eq. (25), which is needed for the completion of the derivation of the expansion history atu of the universe, as we will see below. The whole procedure is repeated for whatever set of scale factors au=atu that we have chosen. Here we have done the calculations for equidistant steps in logau from −12 to +4, on a scale where logau=0 corresponds to the present epoch.
The scale factor aeq at equipartition between the energy densities of matter and radiation is given by
aeq=ΩRa0/ΩMa0.E28
We further note that the scale factor uniquely determines the temperature of the cosmic radiation background through
Tu=2.725/au,E29
which is valid back to a temperature Tu≈109 K. Note that Tu is defined to represent the temperature of the photons. The numerical factor (in units of K) is fixed by the observed value of the CMB temperature at au=1. Above Tu≈1010 K the scaling with au is the same, and Tu is identical to the neutrino temperature Tν, but the proportionality factor is about 40% smaller. Between approximately 1010 and 109 K, the positrons annihilate with the electrons, which leads to the release of energy in the form of gamma radiation that heats the photon gas without affecting the neutrino background. This is the reason why the photon temperature Tu has since been 40% larger than that of the neutrinos. The distinction between Tu and Tν is of relevance for Big Bang nucleosynthesis (BBN) calculations.
Because Tu scales with 1/au according to Eq. (29) and uR scales with Tu4 according to Eq. (27), the radiative energy density ΩRauρcau scales with 1/au4 as required. By enforcing the ΩRau/ΩMau ratio to scale as 1/au during the iteration, we are guaranteed to get the correct 1/au3 scaling for the energy density of matter ΩMauρcau.
In Figure 1 the parameters xu (left panel) and gu (right panel) have been plotted as functions of logau for AC theory (solid curves) and for standard cosmology (dashed curves). The left vertical dotted line in each panel marks the epoch of equipartition between matter and radiation, while the right dotted line represents the present epoch (when the scale factor is normalized to unity). Note how according to standard theory we happen to live at a special time when the xu and gu ratios are beginning to skyrocket. In contrast, in AC theory these ratios are constant at levels that are different when the universe is radiation and matter dominated, with a transition from one level to the other between the epoch of equipartition and the present time.
Figure 1.
The left panel shows xu, defined by Eq. (24) as the ratio between the conformal age ηu and the Hubble time 1/Hu, plotted vs. log of the scale factor at, while the right panel gives the corresponding plot for gu, which is defined by Eq. (25) as the ratio between the proper age tu and the Hubble time 1/Hu. In both panels the AC theory is represented by the solid curve, the standard theory by the dashed curve. The two vertical dotted lines mark the epochs of equipartition and our present time. The dash-dotted curve in the right panel represents the exponent α in the power law representation of the scale factor in Eq. (33). According to standard theory, the current epoch marks the beginning of an inflationary phase that will last forever.
4.4 Solution for the time scale
The next step of the calculation is to use the solution for gu to derive the functions for the epochs tuau and ηuau, the expansion rate Huau, and the acceleration parameter quau.
The proper age tu can be obtained through integration of the function gu. First we realize that the defining equation for gu in Eq. (25) can be expressed as
dlogaudlogtu=Hutu=gu.E30
It can be solved by integration to obtain the proper age tu of the universe as a function of scale factor au:
logtu=∫0logau1/gu′dlogau′+logt0.E31
The present age t0 is obtained from the observed value H0 of the Hubble constant and the value of gua0≡g0 for the present epoch through
logt0=logg0−logH0,E32
which readily follows from the definition of gu in Eq. (25).
The left panel of Figure 2 shows logau as a function of logtu/t0. AC theory is represented by the solid curve, standard cosmology by the dashed curve. The horizontal dotted line marks the scale factor at equipartition between matter and radiation. The slope of the AC evolution in the log-log representation is nearly constant throughout all epochs, both in the past and the future. There is nothing special about our present epoch. In contrast, according to standard theory we happen to live at the start of an inflationary phase that will be everlasting, driven by some mysterious “dark energy.”
Figure 2.
In the left panel, the log of the scale factor at is plotted vs. log of proper time t in units of the present age t0 of the universe. In the right panel, the log of the Hubble time in seconds is plotted vs. log of the temperature (K) of the cosmic background of electromagnetic radiation. The solid curves in both panels represent the evolution according to AC theory, while the dashed curves represent standard theory. The horizontal dotted line in the left panel marks the epoch of equipartition. The three vertical dotted lines in the right panel mark the temperatures of the present epoch, equipartition, and 1 GK (the approximate onset of nucleosynthesis). Note how in standard theory the evolution has an abrupt change at the present epoch with the onset of an inflationary phase.
Note also that the evolutionary time scales are quite different in the two theories. While both curves coincide at the present epoch, simply because they share the same normalization au=1 at tu=t0, the age difference diverges as we go back in time or forward into the future.
Since the AC evolution is so close to linear in the log–log diagram, it is meaningful to represent it in the form of a power law:
au=tu/t0αau.E33
For clarity we have explicitly written the exponent α as a function of the scale factor au (which implies that it is also a function of time). As the function autu is known from Eq. (31) and Figure 2, the functional form of α is given by
α=logaulogtu/t0.E34
Comparison with Eq. (30) shows that α would be the same as our dimensionless function gu if α were a true constant, independent of au and tu. Since however gu varies with au, the functions αau and guau differ. This is illustrated in the right panel of Figure 1, where the function guau as the solid curve is compared with the function αau as the dash-dotted curve (while gu for standard cosmology is given by the dashed curve).
Since gu in AC theory remains constant in the future, it coincides with the α function there, as expected. However, as we go back in time, there is a transition of gu to a higher level, which is reached around the time of equipartition. Because of this variation, the α function initially diverges from gu but approaches it again asymptotically as we go to ever earlier times.
Overall the temporal variations of α and gu are very modest in AC theory, as expected from the nearly linear behavior in the left panel of Figure 2. In contrast, the variations are quite dramatic in standard cosmology, according to which a veritable “explosion” occurs at the present epoch, when the universe takes off in an exponential, inflationary phase.
Note that the level α=1, which is marked by a horizontal dotted line in the right panel of Figure 1, corresponds to a linear au vs. tu relation with zero acceleration. Below this level we have deceleration, above it acceleration. The circumstance that gu and αau in AC theory remain larger than unity in most of the radiation-dominated era of the early universe implies that the universe evolved with an accelerated expansion throughout this time. This mirrors the behavior of the acceleration parameter qu, which will be derived and displayed in Section 5 and Figure 3.
Figure 3.
Cosmic acceleration parameter qu vs. logau for AC theory (solid) and standard cosmology (dashed). The vertical dotted lines mark the epochs of matter-radiation equipartition and the present time. Positive values of q imply deceleration, negative values acceleration (inflation). Note that according to AC theory the universe has been accelerating throughout the entire radiation-dominated era.
4.5 Solution for the expansion rate
Similar to Eq. (32) we obtain from the definition of gu in Eq. (25) the expansion rate Hu as a function of logtu:
logHu=loggu−logtu.E35
Alternatively we may replace time tu by the scale factor au via the power law description of Eq. (33), to obtain the same result in the form
logHu=−1αaulogau+loggu−logt0.E36
Knowing both Hu and xu, we then get the conformal age ηu of the universe as a function of logau directly from Eq. (24).
In the right panel of Figure 2, the Hubble time 1/Hu is plotted vs. logTu for AC theory (solid curve) and standard cosmology (dashed curve). The three vertical dotted lines represent, from left to right: the present epoch (T = 2.725 K), the epoch of equipartition between matter and radiation, and the BBN epoch when the radiation temperature is 109 K. This is the approximate temperature below which photodissociation of deuterium no longer stands in the way for Big Bang nucleosynthesis. Note how the standard theory curve has an abrupt bend at our present epoch because of the onset of an inflationary expansion. In contrast the AC theory curve remains nearly linear for all epochs, with nothing particular happening at the present epoch.
While the solid and dashed curves for 1/Hu coincide at the present epoch, because they obey the same observational constraint, the standard theory curve immediately diverges from the AC curve in both the future and past directions. In standard theory the expansion rate will be much faster in the future and was also much faster in the past, as compared with AC theory. This expresses the same property that was seen in the left panel of Figure 2 for the evolution of the scale factor a. When the temperature was 109 K, around the BBN epoch, the age of the universe was 158 s or 2.6 min in standard cosmology, while it was 43.5 yr in AC theory, a difference by a factor of 107. Instead of referring to “the first 3 minutes” as the time relevant for the formation of the light elements, we would in AC theory need to refer to “the first century!”
This huge difference has major implications for our understanding of BBN physics. At a first glance, it might seem that it would make AC theory incompatible with the constraints imposed by the observed abundances of the light chemical elements, because the BBN predictions depend on the value of the expansion rate. However, a closer look at the BBN problem shows that the situation is much more complex, because we are in a totally different regime. AC theory may still be compatible with the observational constraints, but this remains an open question. At the time of writing, the required BBN modeling with AC theory is still work in progress.
Similarly the significantly slower expansion rate in AC theory around the epochs of equipartition and recombination will require a reevaluation of the processes that govern the formation of the CMB spectrum. This is needed to allow AC theory to be confronted with the constraints that are imposed by the observed CMB signatures.
5. Natural inflation without new fields
Let us next determine the cosmic acceleration parameter qu in AC theory. The first step is to extract the time derivative ȧu of the scale factor from the Hubble constant Hu:
logȧu=logau+logHu.E37
Its derivative with respect to logtu then gives us the acceleration parameter
qu≡−a¨uauȧu2=−1gudlogȧudlogtu.E38
In contrast, in standard cosmology q is obtained directly (without any use of index u) as a function of scale factor a via the relation qa=H0/Ha20.5ΩMa−3+ΩRa−4−ΩΛ.
Figure 3 shows how standard theory (represented by the dashed curve) has three distinct levels for q. (i) In the early universe, when the universe is radiation dominated, q=1. (ii) After equipartition, there is a transition to a new level (q=1/2), when the universe is matter dominated. (iii) At the present epoch, there is a rapid transition to an inflationary phase that is driven by the dominating “dark energy,” at the level q=−1.
In AC theory there is only a gentle transition around equipartition from a level of qu=−0.042 when radiation dominates over matter, to a level of qu=+0.071 when matter dominates over radiation. The negative level of q implies that the cosmic expansion was in an accelerated phase from the beginning of the Big Bang throughout the entire radiation-dominated era. This could be concluded already from the analysis of the right panel of Figure 1 for gu and αau. Although this accelerated expansion represents a very mild form of inflation, its inflationary effect is nevertheless large, because it persists and accumulates over such a long period. It thereby accomplishes what the postulated violent inflation in the brief GUT era does. In AC theory the radiation era inflation is not postulated. Its magnitude is not a free fitting parameter but a consequence of the global resonance condition, which is the origin of the cosmological constant.
It may seem confusing that the universe is currently accelerating according to standard cosmology, while both Figure 3 and the right panel of Figure 1 show it to be decelerating according to AC theory. The reason is that q in standard theory refers to an apparent, nonlocal acceleration, while qu in AC theory is the physically relevant local acceleration of the scale factor autu in terms of the tu time scale. This scale is different from the look-back time scale, because Λ varies with tu.
When we throughout this chapter have referred to the “observed acceleration” of the cosmic expansion, we have implicitly meant the acceleration that is inferred when the observational data are interpreted with the Friedmann-Lemaître models, because no other framework has been available for describing the observations in terms of an evolving scale factor. The discovery with the supernova observations was that a positive cosmological constant Λ is needed to interpret the data in terms of the standard model and its magnitude could be inferred. Within this framework the inferred value of Λ means that the expansion is accelerating. However, the identical observational data with the same current value for Λ do not imply an acceleration of the local autu scale factor within the AC theory framework. Instead the consistently derived autu function implies a deceleration at the present epoch.
The inference of an acceleration from redshift data depends on the way in which redshift z scales with look-back time as governed by Eq. (17). AC theory does not provide any alternative definition of “look-back time.” It instead explains that the physically relevant time scale is that of tu, the age of the observable universe. This scale represents the local, dynamic time scale that is experienced by an observer (who is always located at z=0). The cosmological constant in AC theory depends on tu in contrast to standard cosmology, while being independent of redshift in both theories. Therefore the local acceleration of autu cannot be derived from redshift observations. In summary: the acceleration inferred from supernova observations is an apparent acceleration. The physically relevant acceleration is the one that refers to the local, dynamic time scale, which is obtained with AC theory.
In standard cosmology an inflationary period in the early universe has been postulated to provide a solution to two fundamental cosmological problems: the horizon and the flatness problem [14]. The remarkable smoothness of the observed CMB tells us that the universe was homogeneous and isotropic on large scales to an extremely high degree (of order 10−5) at the time of decoupling (z≈103). Unless one assumes extraordinarily special and improbable initial conditions, such a smoothness and isotropy can only happen, if regions in the CMB with large angular separation have been in causal contact, to allow them to interact and homogenize.
In a decelerating universe, the radius of the cosmic horizon (e.g., the Hubble radius c/H) increases faster than the expansion of space. If the dynamics of the universe were exclusively governed by matter and radiation, as in the Friedmann models without any cosmological constant, then the universe would always be decelerating. A convenient way to describe this is in terms of the “comoving Hubble radius” rH, defined as c/aH. The temporal derivative of aH equals the acceleration of the scale factor: daH/dt=d2a/dt2. This means that when the acceleration is negative (deceleration), aH decreases, and therefore its inverse (the comoving Hubble radius) increases, and vice versa if we reverse the signs.
The described properties are illustrated in Figure 4, where we have plotted the comoving Hubble radius rH as a function of log of the scale factor for standard cosmology (dashed curves) and AC theory (solid curves). Before the present epoch (marked by the dotted line), rH in the standard theory increases steeply, as a consequence of the gravitational deceleration. This deceleration is caused by the gravitational force from the radiation energy before the epoch of equipartition (marked by the vertical dash-dotted line) and by matter afterwards. Therefore the slope of the dashed curve changes around equipartition. Near the present epoch, the negative pressure from the cosmological constant begins to dominate, which marks the beginning of a phase of eternal acceleration. This causes the dashed curve to abruptly turn over and decrease steeply. Along the entire cosmic timeline, the present epoch is singled out as the epoch when this abrupt turnover takes place.
Figure 4.
Plots of the comoving Hubble radius c/aH vs. log of the scale factor at for AC theory (solid curves) and standard cosmology (dashed curves). In the left panel, a log scale is used for the vertical axis, while a linear scale is used in the right panel. The vertical dash-dotted lines mark the epoch of equipartition, the dotted lines the present epoch. While H0 based on supernova data have been used for all computations with the AC theory (and for the solid curves in this figure), the dotted curve in the right panel represents the results when H0 from CMB data have been used instead. This serves to illustrate the degree of uncertainty that is introduced by the so-called H0 anomaly. Note how the present epoch represents a turning point in cosmic history according to standard cosmology.
Causal contact is only possible over distances that are smaller than the comoving horizon size. As seen by the dashed curve in Figure 4, the largest scales that we observe today (of order 10 Gly, the approximate present Hubble radius) only came into causal contact very recently, well after the time of recombination (a≈10−3). It means that they did not have time to interact and thermalize on the Hubble time scale. This makes it a mystery to standard theory why there are such strong correlations in the CMB over regions on the sky with wide angular separations.
To solve this problem, an early inflationary phase without known physical origin was postulated [14]. With its negative slope for rH, it had the purpose of balancing out all the enhancements of rH that have accumulated during the decelerating history of the Friedmann-type evolution of the universe, between the end of inflation until the present time. To avoid wrecking the successful BBN predictions of the Friedmann model, it was believed that the inflationary phase had to end well before the BBN era, which in standard cosmology occurs when the age of the universe is of order minutes. Inspired by the grand unification theory endeavors in particle physics, the inflationary phase is generally postulated to occur in the era of the GUT energies, when the age of the universe was somewhere between 10−36 and 10−32s. When the dashed curve in Figure 4 is continued back to this early era, it has decreased by many orders of magnitude, all of which must be balanced out during the brief inflationary phase. This is why it is generally believed that an incredibly violent inflation must have blown up the scale factor exponentially by about 60 e-foldings, which corresponds to the gigantic number of about 1026.
After the inflation idea was introduced, there have been a plethora of theoretical papers on the subject, which now has a prominent place in all modern cosmology textbooks. Still, four decades after its invention, the hypothetical inflaton field that is assumed to be responsible for the phenomenon has not been identified, in spite of an abundance of searches with string theory, supersymmetric grand unified theories, or other exotic alternatives. The existence of a violently inflationary phase around the GUT era, when the universe was a tiny fraction of a second old, is often treated as a fact, while fundamental arguments against it, like in [15, 16], are largely ignored.
In contrast, the solid curve of the AC theory in Figure 4 shows that the comoving Hubble radius rH has never dipped below a value of 10 Gly, which represents the largest scales that are available in our present observable universe. This can be seen more clearly in the linear representation of the right panel of Figure 4. We already noticed in Figures 1 and 3 that in AC theory the cosmic acceleration occurs naturally throughout the radiation-dominated phase, with a gentle transition to a decelerating phase near the epoch of recombination. Without needing to postulate or assume anything extra, without the introduction of any free parameters, we get a very extended but gentle inflationary phase that extends all the way back to the very beginning of the universe. All scales inside the horizon at the time of recombination (and CMB formation) were always inside the horizon and were therefore causally connected since the beginning. Throughout all of cosmic history until recombination, they could interact with each other and thermalize, to establish a high degree of homogeneity and isotropy. The motivation for postulating a hypothetical GUT era violent inflation does not exist in AC theory. There is no causality problem.
In the right panel of Figure 4, we have let AC theory be represented by two curves. The solid curve is based on the use of a value 73.5 km s−1 Mpc−1 for H0 (the present Hubble constant) from observations of supernovae type Ia, while the dotted curve is based on 66.9 km s−1 Mpc−1 for H0 that has been derived from the interpretation of CMB data from the Planck satellite. These two values of H0 differ by 9.4%, a significant discrepancy that is generally referred to as the “H0 anomaly,” cf. [17]. While this anomaly is an important issue in itself, it does not affect the topics discussed in the present work. We have therefore in all our other figures elected to base all plots for the AC theory on the supernovae H0, including the lines that mark the location of the epoch of equipartition between matter and radiation. In contrast, all the plots for the standard theory are based on H0 from CMB data (for reasons of self-consistency of the standard framework, because all the other parameters that define standard cosmology have been determined primarily from CMB data).
The linear representation of the right panel of Figure 4 again highlights how the present epoch is singled out by the standard model as something extraordinarily special. The comoving Hubble radius has one single narrow peak throughout all of cosmic history, and this peak is located where we happen to live in cosmic time.
6. Conclusions
The cosmological constant Λ that was needed to model the observed accelerated expansion of the universe has generally been interpreted as representing some mysterious “dark energy.” However, the interpretation that dark energy is some kind of new physical field that pervades all of space leads to a cosmology (which is generally referred to as the “standard model”), in which our time in cosmic history is extraordinarily special and marks the onset of an inflationary phase that will continue forever.
Forty years ago another inflationary phase was postulated to occur in the GUT era of the very early universe, in order to answer the question why the universe is observed to be so homogeneous and isotropic on large scales [14]. The scalar inflaton field needed to drive the inflation has however not been identified in spite of a profusion of papers on this topic.
In the present work, we show that both these problems are connected and can be solved, if the Λ term that is responsible for the accelerated expansion is not a physical field but instead due to a global boundary constraint. This constraint induces a Λ term with a magnitude that tracks the conformal age ηu of the universe, such that Λ∼1/ηu2. The density of dark energy therefore vanishes in the distant future. For the implementation of this idea, it is necessary to recognize the participatory role of observers in the universe, which has a profound effect on the nature of the theory.
We have derived and solved the mathematical equations that follow from this approach. It leads to a very different cosmological framework, which we refer to as the “AC theory” (AC for alternative cosmology). Some implications of this theory have been highlighted: The cosmic coincidence problem disappears, our epoch is not special in any way, and we are not privileged observers. The boundary constraint leads to an evolving scale factor that describes an accelerating, inflating phase from the beginning of the Big Bang throughout the entire radiation-dominated era. There is no need to postulate some early violent inflation driven by some hypothetical inflaton field, because the boundary constraint automatically causes the universe to inflate. The theory reproduces the observed value of ΩΛ without the use of any free parameters. Because there is only one, unique solution, the possibility of parallel universes with other values of the cosmological constant does not exist.
As the cosmic expansion rate is found to have been much slower in the past than it was according to standard cosmology, the various observational data need to be reinterpreted with the new framework, in particular the BBN predictions of the abundances of the light chemical elements, and the observed signatures in the cosmic microwave background. The confrontation of the theory with such observational constraints represents work in progress that may ultimately determine the viability of the theory in its present form.
\n',keywords:"dark energy, cosmology, theory, inflation, gravitation, early universe",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/71239.pdf",chapterXML:"https://mts.intechopen.com/source/xml/71239.xml",downloadPdfUrl:"/chapter/pdf-download/71239",previewPdfUrl:"/chapter/pdf-preview/71239",totalDownloads:253,totalViews:0,totalCrossrefCites:0,dateSubmitted:"November 21st 2019",dateReviewed:"January 30th 2020",datePrePublished:"February 25th 2020",datePublished:"May 27th 2020",dateFinished:null,readingETA:"0",abstract:"When supernova observations in the end of the 1990s showed the cosmic expansion to be accelerating, it became necessary to reintroduce the cosmological constant Λ as a fitting parameter. Although its physical origin has remained a mystery, it has generally been interpreted as some kind of energy field referred to as “dark energy.” This interpretation however implies a cosmic coincidence problem because we happen to live at a time when dark energy becomes the dominant driver of the expansion. Here we present an alternative explanation: The Λ term is induced by a global boundary constraint that ties its value to the conformal age of the universe. The cosmic coincidence problem then goes away. We illustrate how the cosmological evolution that is implied by this constraint differs from standard cosmology. Without the use of any free parameters, the theory predicts a present value of Λ that is within 2σ from the value derived from CMB observations with the Planck satellite. The universe is found to be mildly inflationary throughout the entire radiation-dominated era. This obviates the need to postulate a hypothetical, violent grand unification theory (GUT) era inflation to explain the observed large-scale homogeneity and isotropy of the universe.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/71239",risUrl:"/chapter/ris/71239",signatures:"Jan Olof Stenflo",book:{id:"9982",title:"Cosmology 2020",subtitle:"The Current State",fullTitle:"Cosmology 2020 - The Current State",slug:"cosmology-2020-the-current-state",publishedDate:"May 27th 2020",bookSignature:"Michael L. Smith",coverURL:"https://cdn.intechopen.com/books/images_new/9982.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"59479",title:"Dr.",name:"Michael L.",middleName:null,surname:"Smith",slug:"michael-l.-smith",fullName:"Michael L. Smith"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"315797",title:"Emeritus Prof.",name:"Jan",middleName:"Olof",surname:"Stenflo",fullName:"Jan Stenflo",slug:"jan-stenflo",email:"stenflo@astro.phys.ethz.ch",position:null,institution:null}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Resonant origin of the Λ term",level:"1"},{id:"sec_2_2",title:"2.1 Link between Λ and the age of the universe",level:"2"},{id:"sec_3_2",title:"2.2 Resonant amplitude and the validity of the weak-field approximation",level:"2"},{id:"sec_4_2",title:"2.3 Nature of the global constraint for Λ",level:"2"},{id:"sec_6",title:"3. The participatory role of observers",level:"1"},{id:"sec_7",title:"4. Derivation of the cosmological evolution",level:"1"},{id:"sec_7_2",title:"4.1 Key difference between standard cosmology and AC theory",level:"2"},{id:"sec_8_2",title:"4.2 Theoretical justification for the flatness assumption",level:"2"},{id:"sec_9_2",title:"4.3 Iterative solution of the basic equations",level:"2"},{id:"sec_10_2",title:"4.4 Solution for the time scale",level:"2"},{id:"sec_11_2",title:"4.5 Solution for the expansion rate",level:"2"},{id:"sec_13",title:"5. Natural inflation without new fields",level:"1"},{id:"sec_14",title:"6. Conclusions",level:"1"}],chapterReferences:[{id:"B1",body:'Einstein A. Kosmologische Betrachtungen zur allgemeinen Relativitätstheorie. Berlin: Sitzungsberichte der Königlich Preußischen Akademie der Wissenschaften; 1917. pp. 142-152'},{id:"B2",body:'Riess AG, Filippenko AV, Challis P, et al. Observational evidence from supernovae for an accelerating universe and a cosmological constant. Astronomical Journal. 1998;116:1009-1038'},{id:"B3",body:'Perlmutter S, Aldering G, Goldhaber G, et al. Measurements of Ω and Λ from 42 high-redshift supernovae. Astrophysical Journal. 1999;517:565-586'},{id:"B4",body:'Binétruy P. Dark energy and fundamental physics. Astronomy & Astrophysics Review. 2013;21:67'},{id:"B5",body:'Öztas AM, Dil E, Smith ML. The varying cosmological constant: A new approximation to the Friedmann equations and universe model. Monthly Notices of the Royal Astronomical Society. 2018;476(1):451-458'},{id:"B6",body:'Sabulsky DO, Dutta I, Hinds EA, et al. Experiment to detect dark energy forces using atom interferometry. Physical Review Letters. 2019;123(6):061102'},{id:"B7",body:'Colin J, Mohayaee R, Rameez M, Sarkar S. Evidence for anisotropy of cosmic acceleration. Astronomy & Astrophysics. 2019;631:L13'},{id:"B8",body:'Stenflo JO. Origin of the cosmological constant. Astrophysics & Space Science. 2019;364(9):143'},{id:"B9",body:'Planck Collaboration, Aghanim N, Akrami Y, Ashdown M, et al. Planck 2018 results. VI. Cosmological parameters. 2018. arXiv e-prints: http://arxiv.org/abs/1807.06209v1'},{id:"B10",body:'McCoy BM. The connection between statistical mechanics and quantum field theory. 1994. arXiv e-prints: https://arxiv.org/abs/hep-th/9403084'},{id:"B11",body:'Zee A. Quantum Field Theory in a Nutshell. 2nd ed. Princeton: Princeton University Press; 2010'},{id:"B12",body:'Weinberg S. Gravitation and Cosmology: Principles and Applications of the General Theory of Relativity. New York: John Wiley & Sons, Inc.; 1972'},{id:"B13",body:'Peebles PJE. Principles of Physical Cosmology. Princeton: Princeton University Press; 1993'},{id:"B14",body:'Guth AH. Inflationary universe: A possible solution to the horizon and flatness problems. Physical Review D. 1981;23(2):347-356'},{id:"B15",body:'Penrose R. The Road to Reality : A Complete Guide to the Laws of the Universe. London: Vintage Books; 2004'},{id:"B16",body:'Penrose R. Fashion, Faith, and Fantasy in the New Physics of the Universe. Princeton: Princeton University Press; 2016'},{id:"B17",body:'Riess AG, Casertano S, Yuan W, et al. New parallaxes of galactic Cepheids from spatially scanning the Hubble space telescope: Implications for the Hubble constant. Astrophysical Journal. 2018;855:136'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Jan Olof Stenflo",address:"stenflo@astro.phys.ethz.ch",affiliation:'
Institute for Particle Physics and Astrophysics, ETH Zurich, Switzerland
'}],corrections:null},book:{id:"9982",title:"Cosmology 2020",subtitle:"The Current State",fullTitle:"Cosmology 2020 - The Current State",slug:"cosmology-2020-the-current-state",publishedDate:"May 27th 2020",bookSignature:"Michael L. Smith",coverURL:"https://cdn.intechopen.com/books/images_new/9982.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"59479",title:"Dr.",name:"Michael L.",middleName:null,surname:"Smith",slug:"michael-l.-smith",fullName:"Michael L. Smith"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},profile:{item:{id:"185489",title:"Dr.",name:"Joanna",middleName:null,surname:"Jerzyńska",email:"joannajerzynska@gmail.com",fullName:"Joanna Jerzyńska",slug:"joanna-jerzynska",position:null,biography:null,institutionString:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",totalCites:0,totalChapterViews:"0",outsideEditionCount:0,totalAuthoredChapters:"1",totalEditedBooks:"0",personalWebsiteURL:null,twitterURL:null,linkedinURL:null,institution:null},booksEdited:[],chaptersAuthored:[{title:"Immunomodulatory Effect of Vitamin D in Children with Allergic Diseases",slug:"immunomodulatory-effect-of-vitamin-d-in-children-with-allergic-diseases",abstract:"The discovery that many cells express vitamin D receptors and the recognition of widespread vitamin D insufficiency has stimulated interest in the potential role of vitamin D in nonskeleton conditions. There is an increasing evidence to support the role of vitamin D pathway in the regulation of the function of both innate and adoptive immune systems. Vitamin D regulates immune function by inhibiting the differentiation and maturation of human dendritic cells, enhancing interleukin (IL)-10 and tumor growth factor-β (TGF-β) secretion and inhibiting T-cell functions. Vitamin D has the ability to suppress inflammatory cytokines, such as tumor necrosis factor (TNF), interleukin-1 (IL-1), interferon gamma (IFN-γ), and interleukin-2 (IL-2), while it increases the generation of anti-inflammatory cytokines IL-4 and IL-10. In B cells, vitamin D3 has also been shown to suppress immunoglobulin E (IgE) antibody class switch partly through the inhibition of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB).",signatures:"Iwona Stelmach, Joanna Jerzyńska and Daniela Podlecka",authors:[{id:"178132",title:"Prof.",name:"Iwona",surname:"Stelmach",fullName:"Iwona Stelmach",slug:"iwona-stelmach",email:"iwona.stelmach@kopernik.lodz.pl"},{id:"185489",title:"Dr.",name:"Joanna",surname:"Jerzyńska",fullName:"Joanna Jerzyńska",slug:"joanna-jerzynska",email:"joannajerzynska@gmail.com"},{id:"185490",title:"Dr.",name:"Daniela",surname:"Podlecka",fullName:"Daniela Podlecka",slug:"daniela-podlecka",email:"daniela.podlecka@o2.pl"}],book:{title:"A Critical Evaluation of Vitamin D",slug:"a-critical-evaluation-of-vitamin-d-basic-overview",productType:{id:"1",title:"Edited Volume"}}}],collaborators:[{id:"181499",title:"Prof.",name:"John",surname:"Sayer",slug:"john-sayer",fullName:"John Sayer",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"181842",title:"Prof.",name:"Ayman",surname:"Al-Hendy",slug:"ayman-al-hendy",fullName:"Ayman Al-Hendy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Augusta University",institutionURL:null,country:{name:"United States of America"}}},{id:"182113",title:"Dr.",name:"Akira",surname:"Wagatsuma",slug:"akira-wagatsuma",fullName:"Akira Wagatsuma",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Tokyo",institutionURL:null,country:{name:"Japan"}}},{id:"185772",title:"Dr.",name:"Heba",surname:"Elhusseini",slug:"heba-elhusseini",fullName:"Heba Elhusseini",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"185773",title:"Dr.",name:"Daria",surname:"Lizneva",slug:"daria-lizneva",fullName:"Daria Lizneva",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"185774",title:"Dr.",name:"Larisa",surname:"Gavrilova-Jordan",slug:"larisa-gavrilova-jordan",fullName:"Larisa Gavrilova-Jordan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"185775",title:"Dr.",name:"Noura",surname:"Eziba",slug:"noura-eziba",fullName:"Noura Eziba",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"185776",title:"Dr.",name:"Mohamed",surname:"Abdelaziz",slug:"mohamed-abdelaziz",fullName:"Mohamed Abdelaziz",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"185777",title:"Dr.",name:"Soumia",surname:"Brakta",slug:"soumia-brakta",fullName:"Soumia Brakta",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"185778",title:"Prof.",name:"Sunil",surname:"Halder",slug:"sunil-halder",fullName:"Sunil Halder",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]},generic:{page:{slug:"open-access-funding-funders-list",title:"List of Funders by Country",intro:"
If your research is financed through any of the below-mentioned funders, please consult their Open Access policies or grant ‘terms and conditions’ to explore ways to cover your publication costs (also accessible by clicking on the link in their title).
\n\n
IMPORTANT: You must be a member or grantee of the listed funders in order to apply for their Open Access publication funds. Do not attempt to contact the funders if this is not the case.
",metaTitle:"List of Funders by Country",metaDescription:"If your research is financed through any of the below-mentioned funders, please consult their Open Access policies or grant ‘terms and conditions’ to explore ways to cover your publication costs (also accessible by clicking on the link in their title).",metaKeywords:null,canonicalURL:"/page/open-access-funding-funders-list",contentRaw:'[{"type":"htmlEditorComponent","content":"
UK Research and Innovation (former Research Councils UK (RCUK) - including AHRC, BBSRC, ESRC, EPSRC, MRC, NERC, STFC.) Processing charges for books/book chapters can be covered through RCUK block grants which are allocated to most universities in the UK, which then handle the OA publication funding requests. It is at the discretion of the university whether it will approve the request.)
UK Research and Innovation (former Research Councils UK (RCUK) - including AHRC, BBSRC, ESRC, EPSRC, MRC, NERC, STFC.) Processing charges for books/book chapters can be covered through RCUK block grants which are allocated to most universities in the UK, which then handle the OA publication funding requests. It is at the discretion of the university whether it will approve the request.)
Wellcome Trust (Funding available only to Wellcome-funded researchers/grantees)
\n
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5766},{group:"region",caption:"Middle and South America",value:2,count:5228},{group:"region",caption:"Africa",value:3,count:1717},{group:"region",caption:"Asia",value:4,count:10370},{group:"region",caption:"Australia and Oceania",value:5,count:897},{group:"region",caption:"Europe",value:6,count:15790}],offset:12,limit:12,total:118192},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{sort:"dateendthirdsteppublish"},books:[],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:16},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:4},{group:"topic",caption:"Business, Management and Economics",value:7,count:1},{group:"topic",caption:"Chemistry",value:8,count:8},{group:"topic",caption:"Computer and Information Science",value:9,count:6},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:7},{group:"topic",caption:"Engineering",value:11,count:16},{group:"topic",caption:"Environmental Sciences",value:12,count:2},{group:"topic",caption:"Immunology and Microbiology",value:13,count:3},{group:"topic",caption:"Materials Science",value:14,count:5},{group:"topic",caption:"Mathematics",value:15,count:1},{group:"topic",caption:"Medicine",value:16,count:24},{group:"topic",caption:"Neuroscience",value:18,count:1},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:3},{group:"topic",caption:"Physics",value:20,count:2},{group:"topic",caption:"Psychology",value:21,count:4},{group:"topic",caption:"Robotics",value:22,count:1},{group:"topic",caption:"Social Sciences",value:23,count:2},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:1}],offset:0,limit:12,total:null},popularBooks:{featuredBooks:[],offset:0,limit:12,total:null},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9671",title:"Macrophages",subtitle:null,isOpenForSubmission:!1,hash:"03b00fdc5f24b71d1ecdfd75076bfde6",slug:"macrophages",bookSignature:"Hridayesh Prakash",coverURL:"https://cdn.intechopen.com/books/images_new/9671.jpg",editors:[{id:"287184",title:"Dr.",name:"Hridayesh",middleName:null,surname:"Prakash",slug:"hridayesh-prakash",fullName:"Hridayesh Prakash"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10432",title:"Casting Processes and Modelling of Metallic Materials",subtitle:null,isOpenForSubmission:!1,hash:"2c5c9df938666bf5d1797727db203a6d",slug:"casting-processes-and-modelling-of-metallic-materials",bookSignature:"Zakaria Abdallah and Nada Aldoumani",coverURL:"https://cdn.intechopen.com/books/images_new/10432.jpg",editors:[{id:"201670",title:"Dr.",name:"Zak",middleName:null,surname:"Abdallah",slug:"zak-abdallah",fullName:"Zak Abdallah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7841",title:"New Insights Into Metabolic Syndrome",subtitle:null,isOpenForSubmission:!1,hash:"ef5accfac9772b9e2c9eff884f085510",slug:"new-insights-into-metabolic-syndrome",bookSignature:"Akikazu Takada",coverURL:"https://cdn.intechopen.com/books/images_new/7841.jpg",editors:[{id:"248459",title:"Dr.",name:"Akikazu",middleName:null,surname:"Takada",slug:"akikazu-takada",fullName:"Akikazu Takada"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editedByType:"Edited by",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editedByType:"Edited by",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editedByType:"Edited by",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editedByType:"Edited by",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8098",title:"Resources of Water",subtitle:null,isOpenForSubmission:!1,hash:"d251652996624d932ef7b8ed62cf7cfc",slug:"resources-of-water",bookSignature:"Prathna Thanjavur Chandrasekaran, Muhammad Salik Javaid, Aftab Sadiq",coverURL:"https://cdn.intechopen.com/books/images_new/8098.jpg",editedByType:"Edited by",editors:[{id:"167917",title:"Dr.",name:"Prathna",middleName:null,surname:"Thanjavur Chandrasekaran",slug:"prathna-thanjavur-chandrasekaran",fullName:"Prathna Thanjavur Chandrasekaran"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editedByType:"Edited by",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10432",title:"Casting Processes and Modelling of Metallic Materials",subtitle:null,isOpenForSubmission:!1,hash:"2c5c9df938666bf5d1797727db203a6d",slug:"casting-processes-and-modelling-of-metallic-materials",bookSignature:"Zakaria Abdallah and Nada Aldoumani",coverURL:"https://cdn.intechopen.com/books/images_new/10432.jpg",editedByType:"Edited by",editors:[{id:"201670",title:"Dr.",name:"Zak",middleName:null,surname:"Abdallah",slug:"zak-abdallah",fullName:"Zak Abdallah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9671",title:"Macrophages",subtitle:null,isOpenForSubmission:!1,hash:"03b00fdc5f24b71d1ecdfd75076bfde6",slug:"macrophages",bookSignature:"Hridayesh Prakash",coverURL:"https://cdn.intechopen.com/books/images_new/9671.jpg",editedByType:"Edited by",editors:[{id:"287184",title:"Dr.",name:"Hridayesh",middleName:null,surname:"Prakash",slug:"hridayesh-prakash",fullName:"Hridayesh Prakash"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8415",title:"Extremophilic Microbes and Metabolites",subtitle:"Diversity, Bioprospecting and Biotechnological Applications",isOpenForSubmission:!1,hash:"93e0321bc93b89ff73730157738f8f97",slug:"extremophilic-microbes-and-metabolites-diversity-bioprospecting-and-biotechnological-applications",bookSignature:"Afef Najjari, Ameur Cherif, Haïtham Sghaier and Hadda Imene Ouzari",coverURL:"https://cdn.intechopen.com/books/images_new/8415.jpg",editedByType:"Edited by",editors:[{id:"196823",title:"Dr.",name:"Afef",middleName:null,surname:"Najjari",slug:"afef-najjari",fullName:"Afef Najjari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9731",title:"Oxidoreductase",subtitle:null,isOpenForSubmission:!1,hash:"852e6f862c85fc3adecdbaf822e64e6e",slug:"oxidoreductase",bookSignature:"Mahmoud Ahmed Mansour",coverURL:"https://cdn.intechopen.com/books/images_new/9731.jpg",editedByType:"Edited by",editors:[{id:"224662",title:"Prof.",name:"Mahmoud Ahmed",middleName:null,surname:"Mansour",slug:"mahmoud-ahmed-mansour",fullName:"Mahmoud Ahmed Mansour"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"53",title:"Genomics",slug:"genomics",parent:{title:"Biochemistry, Genetics and Molecular Biology",slug:"biochemistry-genetics-and-molecular-biology"},numberOfBooks:14,numberOfAuthorsAndEditors:301,numberOfWosCitations:99,numberOfCrossrefCitations:73,numberOfDimensionsCitations:170,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"genomics",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"9394",title:"Genotoxicity and Mutagenicity",subtitle:"Mechanisms and Test Methods",isOpenForSubmission:!1,hash:"9ee7e597358dbbfb5e33d0beb76e6fff",slug:"genotoxicity-and-mutagenicity-mechanisms-and-test-methods",bookSignature:"Sonia Soloneski and Marcelo L. Larramendy",coverURL:"https://cdn.intechopen.com/books/images_new/9394.jpg",editedByType:"Edited by",editors:[{id:"14863",title:"Dr.",name:"Sonia",middleName:null,surname:"Soloneski",slug:"sonia-soloneski",fullName:"Sonia Soloneski"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8992",title:"Gene Expression and Phenotypic Traits",subtitle:null,isOpenForSubmission:!1,hash:"88ec966a7a8eecaf5cdbdc8b20295737",slug:"gene-expression-and-phenotypic-traits",bookSignature:"Yuan-Chuan Chen and Shiu-Jau Chen",coverURL:"https://cdn.intechopen.com/books/images_new/8992.jpg",editedByType:"Edited by",editors:[{id:"185559",title:"Dr.",name:"Yuan-Chuan",middleName:null,surname:"Chen",slug:"yuan-chuan-chen",fullName:"Yuan-Chuan Chen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9377",title:"Non-Coding RNAs",subtitle:null,isOpenForSubmission:!1,hash:"ff4f15e339216fa9426d2b9fdf3b5901",slug:"non-coding-rnas",bookSignature:"Lütfi Tutar, Sümer Aras and Esen Tutar",coverURL:"https://cdn.intechopen.com/books/images_new/9377.jpg",editedByType:"Edited by",editors:[{id:"158530",title:"Dr.",name:"Lütfi",middleName:null,surname:"Tutar",slug:"lutfi-tutar",fullName:"Lütfi Tutar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6582",title:"Chromatin and Epigenetics",subtitle:null,isOpenForSubmission:!1,hash:"afa23decc7c15bdf48cfeebb5f0c38fb",slug:"chromatin-and-epigenetics",bookSignature:"Colin Logie and Tobias Aurelius Knoch",coverURL:"https://cdn.intechopen.com/books/images_new/6582.jpg",editedByType:"Edited by",editors:[{id:"212809",title:"Associate Prof.",name:"Colin",middleName:null,surname:"Logie",slug:"colin-logie",fullName:"Colin Logie"}],equalEditorOne:{id:"68430",title:"Dr.",name:"Tobias Aurelius",middleName:null,surname:"Knoch",slug:"tobias-aurelius-knoch",fullName:"Tobias Aurelius Knoch",profilePictureURL:"https://mts.intechopen.com/storage/users/68430/images/system/68430.png",biography:"Born in the Rhein-Neckar region Mannheim/Heidelberg, Germany, Dr. Knoch studied Physics, Mathematics, and Biology at the University of Heidelberg. In 1998, he graduated in (bio-)physics with 'Three-Dimensional Organization of Chromosomes domains in Simulation and Experiment”, followed by his dissertation 'Approaching the Three-Dimensional Organization of the Human Genome' both at the German Cancer Research Center (DKFZ), Heidelberg, in 2002. In 2002/2004 Dr. Knoch founded his group Biophysical Genomics located at the Kirchhoff Institute for Physics, University of Heidelberg, and until today at the Cell Biology Department, Erasmus Medical Center, Rotterdam, The Netherlands. His work is focusing on the determination and understanding of genome organization from the DNA sequence level to the entire nuclear morphology. Therefore, approaches from theoretical physics have been combined with molecular biology in highly interdisciplinary projects ranging from advanced DNA sequence analyses, parallel high-performance computer modelling of genomic architectures, and new image analysis methods, to advanced fluorescence in situ hybridization and high-resolution chromatin conformation interaction genome mapping. Major achievements have been: an artefact-free in vivo labelling method of nuclear chromatin, the first system-biological genome browser (GLOBE 3D Genome Browser), the set-up of one of the largest desktop computing grids, and last but not least the final determination of the general structural organization of higher mammalian genomes leading to a consistent systems genomics view of genomes from genotype to phenotype. All this has resulted in patents, publications, the foundation/coordination of international interdisciplinary cooperative networks, and consortia. He also (co-)founded many initiatives improving institutional/university study and management performance including the science outreach to the public and industry. Besides, he also conducts environmental and human ecology research, has achieved law-changing contributions in the human-rights sector, is an increasingly recognized artist in the fine arts, and last but not least has founded and is running two companies in the renewable energy production and development sector. His achievements have resulted in prestigious scholarships, awards, and prices as early as 1983.",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Erasmus University Medical Center",institutionURL:null,country:{name:"Netherlands"}}},equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6987",title:"Antisense Therapy",subtitle:null,isOpenForSubmission:!1,hash:"5d60550dc1e3afbb083fe61925b33caa",slug:"antisense-therapy",bookSignature:"Shashwat Sharad and Suman Kapur",coverURL:"https://cdn.intechopen.com/books/images_new/6987.jpg",editedByType:"Edited by",editors:[{id:"80113",title:"Dr.",name:"Shashwat",middleName:null,surname:"Sharad",slug:"shashwat-sharad",fullName:"Shashwat Sharad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8029",title:"Transcriptome Analysis",subtitle:null,isOpenForSubmission:!1,hash:"19e7bd55dd90a5187ee806a307ef112d",slug:"transcriptome-analysis",bookSignature:"Miroslav Blumenberg",coverURL:"https://cdn.intechopen.com/books/images_new/8029.jpg",editedByType:"Edited by",editors:[{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7995",title:"Epigenetics",subtitle:null,isOpenForSubmission:!1,hash:"33c1f5868ce0c29fbde6eafdc50af702",slug:"epigenetics",bookSignature:"Rosaria Meccariello",coverURL:"https://cdn.intechopen.com/books/images_new/7995.jpg",editedByType:"Edited by",editors:[{id:"143980",title:"Prof.",name:"Rosaria",middleName:null,surname:"Meccariello",slug:"rosaria-meccariello",fullName:"Rosaria Meccariello"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8605",title:"DNA Repair",subtitle:"An Update",isOpenForSubmission:!1,hash:"f32305a1299fabc5119b721f69cc97cb",slug:"dna-repair-an-update",bookSignature:"Maddalena Mognato",coverURL:"https://cdn.intechopen.com/books/images_new/8605.jpg",editedByType:"Edited by",editors:[{id:"41691",title:"Dr.",name:"Maddalena",middleName:null,surname:"Mognato",slug:"maddalena-mognato",fullName:"Maddalena Mognato"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8891",title:"Gene Editing",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"25f0d7de56709fc0558c0bb8212a0d03",slug:"gene-editing-technologies-and-applications",bookSignature:"Yuan-Chuan Chen and Shiu-Jau Chen",coverURL:"https://cdn.intechopen.com/books/images_new/8891.jpg",editedByType:"Edited by",editors:[{id:"185559",title:"Dr.",name:"Yuan-Chuan",middleName:null,surname:"Chen",slug:"yuan-chuan-chen",fullName:"Yuan-Chuan Chen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7331",title:"Modulating Gene Expression",subtitle:"Abridging the RNAi and CRISPR-Cas9 Technologies",isOpenForSubmission:!1,hash:"436fdc4857ca5c7f496e439de1034b6b",slug:"modulating-gene-expression-abridging-the-rnai-and-crispr-cas9-technologies",bookSignature:"Aditi Singh and Mohammad W. Khan",coverURL:"https://cdn.intechopen.com/books/images_new/7331.jpg",editedByType:"Edited by",editors:[{id:"240724",title:"Dr.",name:"Aditi",middleName:null,surname:"Singh",slug:"aditi-singh",fullName:"Aditi Singh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6788",title:"In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders",subtitle:null,isOpenForSubmission:!1,hash:"8cc5d9c7226ec72dfaf15a41133b3d46",slug:"in-vivo-and-ex-vivo-gene-therapy-for-inherited-and-non-inherited-disorders",bookSignature:"Houria Bachtarzi",coverURL:"https://cdn.intechopen.com/books/images_new/6788.jpg",editedByType:"Edited by",editors:[{id:"178430",title:"Dr.",name:"Houria",middleName:null,surname:"Bachtarzi",slug:"houria-bachtarzi",fullName:"Houria Bachtarzi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1719",title:"Genetic Manipulation of DNA and Protein",subtitle:"Examples from Current Research",isOpenForSubmission:!1,hash:"204480b394b0ba9a43580a1e04d53c50",slug:"genetic-manipulation-of-dna-and-protein-examples-from-current-research",bookSignature:"David Figurski",coverURL:"https://cdn.intechopen.com/books/images_new/1719.jpg",editedByType:"Edited by",editors:[{id:"104812",title:"Dr.",name:"David",middleName:null,surname:"Figurski",slug:"david-figurski",fullName:"David Figurski"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:14,mostCitedChapters:[{id:"32799",doi:"10.5772/33525",title:"GC3 Biology in Eukaryotes and Prokaryotes",slug:"gc3-biology-in-eukaryotes-and-prokaryotes",totalDownloads:1495,totalCrossrefCites:7,totalDimensionsCites:14,book:{slug:"dna-methylation-from-genomics-to-technology",title:"DNA Methylation",fullTitle:"DNA Methylation - From Genomics to Technology"},signatures:"Eran Elhaik and Tatiana Tatarinova",authors:[{id:"95992",title:"Dr.",name:"Tatiana",middleName:"Valerievna",surname:"Tatarinova",slug:"tatiana-tatarinova",fullName:"Tatiana Tatarinova"},{id:"105570",title:"Dr.",name:"Eran",middleName:null,surname:"Elhaik",slug:"eran-elhaik",fullName:"Eran Elhaik"}]},{id:"64396",doi:"10.5772/intechopen.81847",title:"MiRNA-Based Therapeutics in Oncology, Realities, and Challenges",slug:"mirna-based-therapeutics-in-oncology-realities-and-challenges",totalDownloads:1087,totalCrossrefCites:2,totalDimensionsCites:9,book:{slug:"antisense-therapy",title:"Antisense Therapy",fullTitle:"Antisense Therapy"},signatures:"Ovidiu Balacescu, Simona Visan, Oana Baldasici, Loredana Balacescu, Catalin Vlad and Patriciu Achimas-Cadariu",authors:[{id:"195763",title:"Ph.D.",name:"Ovidiu",middleName:null,surname:"Balacescu",slug:"ovidiu-balacescu",fullName:"Ovidiu Balacescu"},{id:"196758",title:"Dr.",name:"Loreadana",middleName:null,surname:"Balacescu",slug:"loreadana-balacescu",fullName:"Loreadana Balacescu"},{id:"196770",title:"Prof.",name:"Patriciu",middleName:null,surname:"Achimas",slug:"patriciu-achimas",fullName:"Patriciu Achimas"},{id:"269553",title:"MSc.",name:"Oana",middleName:null,surname:"Baldasici",slug:"oana-baldasici",fullName:"Oana Baldasici"},{id:"269554",title:"Dr.",name:"Simona",middleName:null,surname:"Visan",slug:"simona-visan",fullName:"Simona Visan"},{id:"279298",title:"Dr.",name:"Catalin",middleName:null,surname:"Vlad",slug:"catalin-vlad",fullName:"Catalin Vlad"}]},{id:"42536",doi:"10.5772/35029",title:"Studying Cell Signal Transduction with Biomimetic Point Mutations",slug:"studying-cell-signal-transduction-with-biomimetic-point-mutations",totalDownloads:1918,totalCrossrefCites:0,totalDimensionsCites:8,book:{slug:"genetic-manipulation-of-dna-and-protein-examples-from-current-research",title:"Genetic Manipulation of DNA and Protein",fullTitle:"Genetic Manipulation of DNA and Protein - Examples from Current Research"},signatures:"Nathan A. Sieracki and Yulia A. Komarova",authors:[{id:"102665",title:"Dr.",name:"Yulia",middleName:null,surname:"Komarova",slug:"yulia-komarova",fullName:"Yulia Komarova"},{id:"109090",title:"Dr.",name:"Nathan",middleName:"A.",surname:"Sieracki",slug:"nathan-sieracki",fullName:"Nathan Sieracki"}]}],mostDownloadedChaptersLast30Days:[{id:"66606",title:"Introductory Chapter: Transcriptome Analysis",slug:"introductory-chapter-transcriptome-analysis",totalDownloads:1744,totalCrossrefCites:1,totalDimensionsCites:3,book:{slug:"transcriptome-analysis",title:"Transcriptome Analysis",fullTitle:"Transcriptome Analysis"},signatures:"Miroslav Blumenberg",authors:[{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg"}]},{id:"42537",title:"Recombineering and Conjugation as Tools for Targeted Genomic Cloning",slug:"recombineering-and-conjugation-as-tools-for-targeted-genomic-cloning",totalDownloads:1438,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"genetic-manipulation-of-dna-and-protein-examples-from-current-research",title:"Genetic Manipulation of DNA and Protein",fullTitle:"Genetic Manipulation of DNA and Protein - Examples from Current Research"},signatures:"James W. Wilson, Clayton P. Santiago, Jacquelyn Serfecz and Laura N. Quick",authors:[{id:"124557",title:"Dr.",name:"James",middleName:null,surname:"Wilson",slug:"james-wilson",fullName:"James Wilson"}]},{id:"67830",title:"Antisense Therapy: An Overview",slug:"antisense-therapy-an-overview",totalDownloads:996,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"antisense-therapy",title:"Antisense Therapy",fullTitle:"Antisense Therapy"},signatures:"Shashwat Sharad",authors:[{id:"80113",title:"Dr.",name:"Shashwat",middleName:null,surname:"Sharad",slug:"shashwat-sharad",fullName:"Shashwat Sharad"}]},{id:"67086",title:"Application and Development of CRISPR/Cas9 Technology in Pig Research",slug:"application-and-development-of-crispr-cas9-technology-in-pig-research",totalDownloads:1109,totalCrossrefCites:2,totalDimensionsCites:2,book:{slug:"gene-editing-technologies-and-applications",title:"Gene Editing",fullTitle:"Gene Editing - Technologies and Applications"},signatures:"Huafeng Lin, Qiudi Deng, Lili Li and Lei Shi",authors:null},{id:"38875",title:"How RNA Interference Combat Viruses in Plants",slug:"how-rna-interference-combat-viruses-in-plants",totalDownloads:3569,totalCrossrefCites:2,totalDimensionsCites:4,book:{slug:"functional-genomics",title:"Functional Genomics",fullTitle:"Functional Genomics"},signatures:"Bushra Tabassum, Idrees Ahmad Nasir, Usman Aslam and Tayyab Husnain",authors:[{id:"147560",title:"Prof.",name:"Tayyab",middleName:null,surname:"Husnain",slug:"tayyab-husnain",fullName:"Tayyab Husnain"}]},{id:"64492",title:"Antisense Oligonucleotides, A Novel Developing Targeting Therapy",slug:"antisense-oligonucleotides-a-novel-developing-targeting-therapy",totalDownloads:2255,totalCrossrefCites:2,totalDimensionsCites:5,book:{slug:"antisense-therapy",title:"Antisense Therapy",fullTitle:"Antisense Therapy"},signatures:"Sara Karaki, Clément Paris and Palma Rocchi",authors:[{id:"273516",title:"Dr.",name:"Palma",middleName:null,surname:"Rocchi",slug:"palma-rocchi",fullName:"Palma Rocchi"},{id:"275051",title:"Dr.",name:"Sara",middleName:null,surname:"Karaki",slug:"sara-karaki",fullName:"Sara Karaki"},{id:"282578",title:"Dr.",name:"Clement",middleName:null,surname:"Paris",slug:"clement-paris",fullName:"Clement Paris"}]},{id:"65601",title:"Epigenetic Modifications in Plants under Abiotic Stress",slug:"epigenetic-modifications-in-plants-under-abiotic-stress",totalDownloads:915,totalCrossrefCites:2,totalDimensionsCites:2,book:{slug:"epigenetics",title:"Epigenetics",fullTitle:"Epigenetics"},signatures:"Garima Singroha and Pradeep Sharma",authors:[{id:"142882",title:"Dr.",name:"Pradeep",middleName:null,surname:"Sharma",slug:"pradeep-sharma",fullName:"Pradeep Sharma"},{id:"281215",title:"Dr.",name:"Garima",middleName:null,surname:"Singroha",slug:"garima-singroha",fullName:"Garima Singroha"}]},{id:"63505",title:"Resetting Cell Fate by Epigenetic Reprogramming",slug:"resetting-cell-fate-by-epigenetic-reprogramming",totalDownloads:588,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"chromatin-and-epigenetics",title:"Chromatin and Epigenetics",fullTitle:"Chromatin and Epigenetics"},signatures:"Molly Pui Man Wong and Ray Kit Ng",authors:[{id:"243618",title:"Dr.",name:"Ray Kit",middleName:null,surname:"Ng",slug:"ray-kit-ng",fullName:"Ray Kit Ng"},{id:"257535",title:"Dr.",name:"Molly Pui Man",middleName:null,surname:"Wong",slug:"molly-pui-man-wong",fullName:"Molly Pui Man Wong"}]},{id:"62990",title:"CRISPR-ERA for Switching Off (Onco) Genes",slug:"crispr-era-for-switching-off-onco-genes",totalDownloads:582,totalCrossrefCites:1,totalDimensionsCites:2,book:{slug:"modulating-gene-expression-abridging-the-rnai-and-crispr-cas9-technologies",title:"Modulating Gene Expression",fullTitle:"Modulating Gene Expression - Abridging the RNAi and CRISPR-Cas9 Technologies"},signatures:"Ignacio García-Tuñon, Elena Vuelta, Sandra Pérez-Ramos, Jesús M\nHernández-Rivas, Lucía Méndez, María Herrero and Manuel\nSanchez-Martin",authors:null},{id:"69649",title:"Introductory Chapter: Gene Expression and Phenotypic Traits",slug:"introductory-chapter-gene-expression-and-phenotypic-traits",totalDownloads:372,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"gene-expression-and-phenotypic-traits",title:"Gene Expression and Phenotypic Traits",fullTitle:"Gene Expression and Phenotypic Traits"},signatures:"Yuan-Chuan Chen",authors:[{id:"185559",title:"Dr.",name:"Yuan-Chuan",middleName:null,surname:"Chen",slug:"yuan-chuan-chen",fullName:"Yuan-Chuan Chen"}]}],onlineFirstChaptersFilter:{topicSlug:"genomics",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"profile.detail",path:"/profiles/185489/joanna-jerzynska",hash:"",query:{},params:{id:"185489",slug:"joanna-jerzynska"},fullPath:"/profiles/185489/joanna-jerzynska",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var m;(m=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(m)}()